# **HE 1 - Introduction and Course Overview**  

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Nithiah Thangiah**  
**Acknowledgement: Prof. Ng Chiu Wan, Dept. of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  

---

## ðŸ§­ **1. Course Orientation and Objectives**

**Health Economics** is a critical discipline that examines how **scarce resources** are allocated within the health sector, essential for public health professionals. The **MQB7014: Health Economics** module introduces students to the **aims, concepts, theories, and methods of economic analysis** and their application to **resource allocation, management, evaluation, and planning** in health services.

### ðŸŽ¯ **Aim of the Health Economics Module**
- **Purpose**: To equip students with **economic reasoning skills** to address **health-related challenges**.
- **Encourages Inquiry**: Prompts exploration of **perplexing health issues**, such as:
  - *Micro-level*: *â€œWhy is the pharmacy selling bath soaps and the grocer selling painkillers?â€* ðŸ§¼ðŸ’Š
  - *Macro-level*: *â€œWhere did all our midwives disappear to?â€* or *â€œShould our government be providing private healthcare?â€* ðŸ¥
- **Goal**: Foster a **curious and analytical mindset** to apply **economic logic** to health systems, encouraging students to develop an **inquiring mind**.

### ðŸ“‹ **Pre-requisites for Effective Learning**
To excel, students should exhibit:
- **Willingness to Ask Questions** â“: *â€œDo not keep silent!â€*
- **Curiosity** ðŸ”: *â€œBe curious and chase answers!â€*
- **Healthy Sense of Humor** ðŸ˜„: To engage with complex topics lightheartedly.

---

## ðŸ“… **2. Course Structure and Assessment**

The module combines **lectures, discussions, and assessments** to deliver a comprehensive learning experience, covering foundational and advanced health economics topics.

### ðŸ—‚ï¸ **Module Structure**
- **Delivery**: Interactive **lectures and discussions**.
- **Assessment Breakdown**:
  - **Continuous Assessment (50%)**:
    - **Mid-semester Test (25%)**: Assesses lectures HE 2â€“7.
    - **Group Assignment (25%)**: Includes a seminar presentation and written report.
  - **End-of-Course Examination (50%)**: Comprehensive evaluation of all module content.

### ðŸ“š **Lecture Topics Overview**
| **Week** | **Topic** |
|----------|-----------|
| HE 1 & 2 | Introduction and Basic Economic Tools |
| HE 3     | Demand for Health and Healthcare |
| HE 4     | Financing Healthcare |
| HE 5     | Market for Health Insurance and Managed Care |
| HE 6     | Equality, Equity, and Social Justice |
| HE 7     | Role of the Government in the Health Sector; Economic Evaluations in Health |
| HE 8     | Mid-semester Test |
| HE 9â€“12  | Economic Evaluations in Health Iâ€“IV |
| HE 13    | Seminar Presentation |
| HE 14    | End-of-Course Review |

### ðŸ—“ï¸ **Key Dates**
| **Component**              | **Date**                     | **Details** |
|----------------------------|------------------------------|-------------|
| **Mid-semester Test**      | Thursday, 22nd May 2025      | Covers lectures HE 2â€“7 |
| **Group Assignment Submission** | Thursday, 26th June 2025 (12 noon) | Uploaded via Spectrum |
| **End-of-semester Exam**   | July 2025 (TBD)              | Comprehensive exam |

---

## ðŸ–¼ï¸ **3. Group Assignment: Modified Gallery Walk**

The **group assignment** is a key component, fostering **collaborative analysis** of health economics issues through a **modified Gallery Walk**, an interactive learning approach.

### ðŸ“… **Overview**
- **Date and Time**: Thursday, 19th June 2025, 11:00 AM â€“ 1:00 PM.
- **Format**: Modified Gallery Walk (see [https://serc.carleton.edu/introgeo/gallerywalk/what.html](https://serc.carleton.edu/introgeo/gallerywalk/what.html)).
- **Group Size**: **4 students per group**.
- **Weightage**: **50% of continuous assessment** (25% of total course marks).

### ðŸ› ï¸ **Preparation**
- **Task**:
  - Identify a **â€œperplexingâ€ health issue or question** (e.g., unusual healthcare trends or policy dilemmas).
  - Develop **rational economic explanations**, supported by:
    - **Published articles**, readings, or materials.
    - Discussions with **knowledgeable individuals** (e.g., experts or stakeholders).
- **Output**:
  - Create a **poster** (printed A4 sheets) detailing the issue and economic explanations.

### ðŸŽ¤ **Gallery Walk Process**
- **Setup**: Poster stations at a venue (TBD).
- **Roles**:
  - **Two students** stay at the poster station to:
    - **Present** the issue and explanations.
    - **Pose questions** to visiting students for feedback.
  - **Two students** visit other stations to:
    - **Provide feedback** on other posters.
    - **Ask questions** to presenters.
- **Timing**: **15 minutes per station**.
- **Participation**: **All students** must contribute to presentations and discussions.

### ðŸ“ **Post-Gallery Walk Submission**
- **Requirement**: Submit **one Word document** per group, including:
  - Write-up of the **health issue**.
  - Summary of **discussions and feedback** from the Gallery Walk.
  - **Names of all group members**.
- **Due Date**: Thursday, 26th June 2025, by **12 noon** (via Spectrum).

---

## ðŸŒ **4. Foundations of Economics and Health Economics**

### ðŸ“– **What is Economics?**
- **Definition**: *â€œEconomics is the study of how people make choices under the condition of scarcity and of the results of those choices on society.â€*  
  - Source: Frank R and Bernanke B. (2001). *Principles of Economics*. McGraw-Hill, Singapore, p. 4.
- **Core Concept**: Examines **human behavior** when **resources are limited** and **wants are unlimited**, necessitating **choices** and **trade-offs**.
- **Focus**: *â€œStudy on human behaviour particularly focusing on how choices are made or different alternatives are chosen.â€*

### ðŸ’¡ **Economic Concept of Scarcity**
- **Definition**: *â€œA condition in which people cannot have all the goods and services that they want.â€*
- **Causes**: Human wants **exceed** available resources (e.g., land, labor, capital).
- **Consequences**:
  - Forces **choices** (e.g., prioritizing one service over another).
  - Requires **sacrifices** (e.g., giving up some goods to obtain others).

### ðŸ©º **What is Health Economics?**
- **Definition**: *â€œThe study of how resources are allocated to and within the health economy.â€*  
  - Source: Sherman F, Goodman A C, Stano M. (2005). *The Economics of Health and Health Care*, 4th Ed., p. 1.
- **Focus**: Analyzes **resource allocation** to meet **health needs**, balancing efficiency and equity.

### ðŸ§  **Economics in Everyday Life**
- **Key Insight**: *â€œWe all behave as economists, knowingly or unknowingly.â€*
- **Examples**:
  - **Household Budgeting**: Managing limited income.
  - **Family Decisions**: Choosing to have children or selecting schools.
  - **Consumer Behavior**: Seeking maximum satisfaction at the lowest price (e.g., Lazada/Shopee 11.11/12.12 sales).
  - **Work-Life Balance**: Opting for overtime or prioritizing family time over promotions.

---

## ðŸ“Š **5. Healthcare in Malaysia: 2023 Snapshot**

### ðŸ¥ **Healthcare Utilization (2023)**
| **Indicator**              | **Public Sector** | **Private Sector** |
|----------------------------|-------------------|--------------------|
| **Hospitalizations**       | 2,613,161         | 1,362,564          |
| **Outpatient Attendance**  | 18,956,999        | 4,062,272          |

- **Leading Cause of Hospitalization**: **Diseases of the respiratory system**.

### ðŸ’° **Health Expenditure**
| **Year** | **Sector**                          | **Amount (RM)** |
|----------|-------------------------------------|-----------------|
| 2022     | Total Health Expenditure (Public + Private) | 78,945 million (4.41% of GDP) |
| 2021     | Public Hospitals                    | 23,054 million  |
| 2021     | Private Sector Curative Care        | 21,199 million  |

- **Global Context**: Malaysiaâ€™s health expenditure (4.41% of GDP in 2016) is modest compared to other nations, per WHOâ€™s *World Health Statistics 2019*.

---

## â“ **6. Relevance of Economics in Health**

### ðŸ©º **Why Economics Matters**
- **Resource Consumption**: Healthcare consumes **significant national resources**, competing with sectors like defense, education, housing, and public transportation.
- **Limited Resources**: *â€œNo country can provide unlimited access to quality care.â€*
  - **Rationing** is inevitable due to **boundless health needs** and **limited resources**.
- **Societal Impact**: Policy choices affect society, e.g.:
  - **Free Compulsory Immunizations**: Achieve **herd immunity**.
  - **Public vs. Private Care**: Impacts **equity and accessibility**.
  - **Migrant Healthcare Policies**: Affects local population health.

### ðŸ¤” **Common Doubts**
- **Health as a Technical Matter**: Should be left to experts, not patients.
- **Patient Irrationality**: Patients may not make informed choices.
- **Professional Autonomy**: *â€œThe ability of particular professionals to make decisions that are not subject to authoritative review by those outside of the profession.â€*
- **Health as a Right**: Limited resources shouldnâ€™t restrict access.
- **Market Unsuitability**: Healthcare shouldnâ€™t be left to market forces.

### âœ… **Counterargument: Economics is Essential**
- **Resource Allocation**: Balances health with other societal needs.
- **Prioritization**: Manages **scarce resources** efficiently.
- **Policy Impact**: Ensures decisions benefit society.

---

## ðŸ¥ **7. Why is Healthcare Different?**

Healthcareâ€™s unique characteristics distinguish it from other sectors:

| **Feature**            | **Explanation** |
|------------------------|---------------|
| **Uncertainty** âš•ï¸     | Unpredictable illness occurrence and treatment outcomes. |
| **Asymmetry of Information** ðŸ“š | Professionals know more than patients, as medicine is a technical subject. |
| **Externalities** ðŸ¤   | Interventions (e.g., vaccinations) provide shared benefits (e.g., herd immunity). |
| **Provider Monopolies** ðŸ¥ | Fewer providers limit patient choices, especially in rural areas. |

- **Core Belief**: *â€œMost people value health and consider healthcare a basic human right.â€*

### ðŸ“œ **The Right to Health**
- **Definition**: *â€œThe right to the enjoyment of the highest attainable standard of physical and mental health is a fundamental human right.â€*  
  - Source: OHCHR & WHO. *Right to Health. Fact Sheet 31*.
- **Origin**: Articulated in the **1946 WHO Constitution**, defining health as:
  - *â€œA state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.â€*
- **Implication**: Health is a **universal right**, transcending race, religion, or socioeconomic status.

---

## ðŸ§  **8. Core Economic Concepts**

### ðŸ“š **Defining Health**
- **WHO Definition**: *â€œHealth is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.â€*
- **Evansâ€™ Definition**: *â€œHealthcare includes goods and services used primarily for their anticipated positive impact on health status, distinct from commodities consumed for direct satisfaction.â€*
- **Scope**:
  - **Curing diseases** and managing illnesses.
  - **Health promotion and protection** (e.g., diagnosis, treatment).

### ðŸ” **The Economic Problem**
1. **Limited Resources**: Finite **land, labor, and capital** for producing goods and services.
2. **Unlimited Wants**: Requires **choices** on resource use.
3. **Rational Behavior**: Assumes individuals aim to **maximize benefits** efficiently.
4. **Efficiency**: Achieved by **minimizing costs** to **maximize outcomes**.

### ðŸ“ **Key Economic Terms**
| **Term**                | **Definition** |
|-------------------------|---------------|
| **Microeconomics**      | Focuses on individual units (e.g., patients, providers) and their decisions. |
| **Macroeconomics**      | Examines aggregate decisions (e.g., national health policies) and their economic impact. |
| **Positive Economics**  | Deals with factual assessments (e.g., healthcare spending data). |
| **Normative Economics** | Involves value judgments (e.g., whether healthcare should be free). |

---

## ðŸ¤ **9. The Rational Person**

### ðŸ§‘â€ðŸ’¼ **Who is the Rational Person?**
- **Definition**: *â€œA person with well-defined goals who tries to fulfill those goals as best they can.â€*
- **Characteristics** (Homo Economicus):
  - Possesses **knowledge** and the ability to use it.
  - Can assess **benefits and costs** with certainty.
  - Aims to achieve **maximum utility** within constraints.

### ðŸŽ¯ **What is Utility?**
- **Definition**: *â€œThe advantage, fulfillment, or satisfaction a person receives from consuming goods or services.â€*

### âš–ï¸ **Rational Decision-Making**
- **Principle**: Actions aim to **maximize utility**.
- **Process**: Weighs **costs** (including **opportunity costs**) against **benefits**, often at the **margins**.

---

## ðŸ“‰ **10. Scarcity and Decision-Making**

### ðŸ½ï¸ **Scarcity Principle (No-Free-Lunch Principle)**
- **Definition**: *â€œAlthough we have boundless needs and wants, the resources available to us are limited. So having more of one good usually means having less of another.â€*
- **Implication**: Choices involve **trade-offs** due to resource constraints.

### âš–ï¸ **Cost-Benefit Principle**
- **Definition**: *â€œAn individual (or a firm or society) should take an action if, and only if, the extra benefits from taking the action are at least as great as the extra cost.â€*
- **Formula**: **Benefits â‰¥ Costs**.
- **Example**: Pursuing a **Master of Public Health (MPH)** is rational only if the **benefits** (e.g., career advancement) outweigh the **costs** (e.g., fees, lost income).

### ðŸ’¸ **Opportunity Costs**
- **Definition**: *â€œThe value of the next best alternative that must be forgone to undertake an activity.â€*
- **Key Idea**: Using resources in one way **prevents their use elsewhere**, and the cost is the **best alternative forgone**.
- **Example**:
  - **Choice**: Studying for an MPH.
  - **Costs**: RM 4,800/month (fees: RM 800, expenses: RM 2,000, lost salary: RM 2,000).
  - **Opportunity Cost**: Forgoing a job with a **RM 2,000/month salary**.
- **Implication**: *â€œThe fact that you are here means that the benefits of pursuing a masterâ€™s in UM are worth at least RM 4,800 a month to you.â€*

### ðŸ“Š **Illustrative Cost Breakdown (Fictional)**
| **Cost Component**         | **Amount (RM/month)** |
|----------------------------|-----------------------|
| Tuition Fees               | 800                   |
| Living Expenses (Rental, Food, Transport) | 2,000         |
| Lost Salary (Opportunity Cost) | 2,000             |
| **Total**                  | **4,800**             |

---

## ðŸ° **11. Case Study: Siti the Homemaker**

### ðŸ“– **Scenario**
- **Context**: Siti, a homemaker, plans to bake **cakes and cookies** for Hari Raya with a **RM 120 budget** for ingredients (flour, butter, sugar).
- **Challenge**: Decide how many **cakes** or **tins of cookies** to produce.
- **Tool**: **Production Possibility Curve (PPC)** to visualize trade-offs, showing combinations of cakes and cookies possible within the budget.

### ðŸ¤” **Decision-Making**
- **Task**: Choose the combination that **maximizes utility** (satisfaction for Hari Raya).
- **Rational Approach**: Weigh **costs** and **benefits** of each option, considering trade-offs (e.g., more cakes mean fewer cookies).

---

## ðŸ“ˆ **12. Marginal Analysis**

### ðŸ” **What is Marginal Analysis?**
- **Definition**: *â€œIn making a decision, the relevant costs and benefits are marginal costs and marginal benefits.â€*
- **Components**:
  - **Marginal Benefits**: Additional gain from consuming/producing **one more unit** of a good/service.
  - **Marginal Costs**: Additional cost of consuming/producing **one more unit**.
- **Focus**: Decisions involve **incremental changes**, not all-or-nothing choices.

### ðŸŒŸ **Relevance**
- **Examples**:
  - Baking **3, 4, or 5 cakes**.
  - Eating **one more slice of bread** instead of one.
  - Building **an additional hospital** or clinic.
- **Application**: Optimizes resource use by evaluating **marginal impacts**, rarely requiring all-or-nothing decisions.

---

## ðŸ¥­ **13. Case Study: The Durian King**

### ðŸŒ³ **Scenario**
- **Context**: Mr. Chan, a durian farmer, uses **fertilizer** to increase durian yield on his fixed land.
- **Goal**: Determine the **optimal amount of fertilizer** to **maximize output** and **profit**.

### ðŸ“Š **Production Data**
| **Kilos of Fertilizer** | **Kilos of Durians** | **Additional Durians** |
|-------------------------|----------------------|------------------------|
| 0                       | 100                  | â€”                      |
| 1                       | 120                  | 20                     |
| 2                       | 128                  | 8                      |
| 3                       | 132                  | 4                      |
| 4                       | 135                  | 3                      |
| 5                       | 137                  | 2                      |
| 6                       | 138                  | 1                      |

### ðŸ’° **Cost-Benefit Analysis**
- **Costs**: 1 kilo of fertilizer = **RM 8.00**.
- **Revenue**: 1 kilo of durians = **RM 5.00**.
- **Marginal Analysis**:
  | **Kilos of Fertilizer** | **Additional Cost (RM)** | **Additional Durians** | **Additional Income (RM)** |
  |-------------------------|--------------------------|------------------------|----------------------------|
  | 1                       | 8.00                     | 20                     | 100.00                     |
  | 2                       | 8.00                     | 8                      | 40.00                      |
  | 3                       | 8.00                     | 4                      | 20.00                      |
  | 4                       | 8.00                     | 3                      | 15.00                      |
  | 5                       | 8.00                     | 2                      | 10.00                      |
  | 6                       | 8.00                     | 1                      | 5.00                       |

- **Optimal Decision**: Stop at **5 kilos of fertilizer**, as the **6th kilo** yields **additional income (RM 5.00)** less than the **additional cost (RM 8.00)**.
- **Profit Analysis**:
  | **Kilos of Fertilizer** | **Cost (RM)** | **Durians (kg)** | **Revenue (RM)** | **Profit (RM)** |
  |-------------------------|---------------|------------------|------------------|-----------------|
  | 0                       | 0             | 100              | 500              | 500             |
  | 1                       | 8             | 120              | 600              | 592             |
  | 2                       | 16            | 128              | 640              | 624             |
  | 3                       | 24            | 132              | 660              | 636             |
  | 4                       | 32            | 135              | 675              | 643             |
  | 5                       | 40            | 137              | 685              | 645             |
  | 6                       | 48            | 138              | 690              | 642             |

### ðŸ“‰ **Law of Diminishing Returns**
- **Definition**: *â€œWhen increasing amounts of a variable factor (e.g., fertilizer) are used with a given amount of a fixed factor (e.g., land), there will come to a point when each unit of the variable factor will produce less and less output than the previous unit.â€*
- **Illustration**: Additional durians decrease from **20 kg** (1st kilo) to **1 kg** (6th kilo), as shown in the graph:
  - **X-axis**: Input of fertilizer (kg).
  - **Y-axis**: Output of durians (kg, ranging from 90 to 150).

---

## ðŸ” **14. Recap of Key Takeaways**

### ðŸ§‘â€ðŸ’¼ **The Rational Person**
- **Definition**: Seeks to **maximize utility** through informed choices.
- **Behavior**: Guided by the aim of **maximizing utility**.

### âš–ï¸ **Rational Decision-Making**
- **Basis**: Examines **costs** (including **opportunity costs**) and **benefits**.
- **Focus**: Often involves **decision-making at the margins**.

### ðŸ“Š **Marginal Analysis**
- **Key Metrics**: **Marginal costs** and **marginal benefits** drive efficient resource allocation.
- **Importance**: Critical for optimizing scarce resources in health and other sectors.

---

# HE 2 - Basic Economic Tools

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Nithiah Thangiah**  
**Acknowledgement: Prof. Ng Chiu Wan, Dept. of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  

---

## ðŸ“š 1. Introduction to Basic Economic Tools  

**Health Economics** employs fundamental economic tools to analyze resource allocation in healthcare systems. This lecture covers **utility measurement**, **supply and demand dynamics**, **price and cross elasticities**, and **market structures**, emphasizing **perfectly competitive markets**. These tools are essential for understanding healthcare markets and informing policy decisions.  

### ðŸŽ¯ Lecture Objectives  
- **Understand**: The dynamics of **supply and demand** in markets.  
- **Explore**: **Utility** and its measurement, including the **diamond-water paradox**.  
- **Analyze**: **Price elasticity** and **cross elasticity** in healthcare contexts.  
- **Examine**: Market structures, particularly **perfect competition**, and their relevance to efficiency.  
- **Apply**: Economic principles to healthcare, supported by empirical studies (e.g., Rand Health Insurance Experiments, Madagascar fee exemptions).  

---

## ðŸ§  2. Measuring Utility  

### ðŸ“ What is Utility?  
- **Definition**: *Utility represents the satisfaction, advantage, or value a person derives from consuming a good or service.*  
- **Measurement Challenge**:  
  - No standardized unit exists (e.g., **â€œUtilsâ€** is a hypothetical concept).  
  - **Money** is used as a proxy, where the **price paid** for a good or service reflects the **satisfaction** (utility) obtained.  
- **Key Insight**: *The price we pay for a good or service reflects the amount of satisfaction or value we obtain from consuming that good or service.*  

### ðŸ’Ž The Diamond-Water Paradox  
- **Concept**: Highlights the discrepancy between **total utility** and **marginal utility**.  
  - **Water**:  
    - High **total utility** due to its essential role in survival.  
    - Low **marginal utility** and price because it is abundant.  
  - **Diamonds**:  
    - Lower **total utility** as they are non-essential.  
    - High **marginal utility** and price due to scarcity.  
- **Implication**: Prices are driven by **scarcity** and **marginal utility**, not just total utility.  

---

## ðŸ“ˆ 3. Dynamics of Demand  

### ðŸ›’ Understanding Demand  
- **Perspective**: From the **customerâ€™s viewpoint**.  
- **Definition**: *Demand is the amount of a product (good or service) that customers are willing and able to buy over a period of time.*  
- **Key Determinants**:  
  - **Price** of the product (primary factor).  
  - **Non-price factors**: Income, prices of related goods (substitutes or complements), consumer preferences, and tastes.  

### âš–ï¸ Law of Demand  
- **Statement**: *Other things being equal, when the price of a product rises, the quantity demanded falls, and when the price falls, the quantity demanded rises.*  
- **Intuition**: Higher prices reduce affordability, decreasing demand, while lower prices increase purchasing power, boosting demand.  

### ðŸ¦ Demand Schedule for Ice Cream Cones  
| **Price per Cone (RM)** | **Quantity Demanded** |
| ----------------------- | --------------------- |
| 0.00                    | 120                   |
| 0.50                    | 100                   |
| 1.00                    | 80                    |
| 1.50                    | 60                    |
| 2.00                    | 40                    |
| 2.50                    | 20                    |
| 3.00                    | 0                     |
- **Observation**: As price increases, quantity demanded decreases, reflecting the **law of demand**.  
- **Graphical Representation**: The **demand curve** slopes **downward** from left to right, showing an inverse price-quantity relationship.  

### ðŸ§® Demand Function  
- **Definition**: *The demand function shows the relationship between quantity demanded and various factors.*  
- **Mathematical Form**:  
  $$ Q_d = f(P, RP, Y, T, \ldots) $$  
  - $Q_d$: Quantity demanded.  
  - $P$: Price of the good.  
  - $RP$: Prices of related goods (substitutes or complements).  
  - $Y$: Income.  
  - $T$: Preferences and tastes of individuals.  
- **Implication**: Demand is multifaceted, influenced by price and non-price factors.  

### ðŸ”„ Movements vs. Shifts in Demand  
- **Movements Along the Demand Curve**:  
  - Caused by **changes in the productâ€™s own price**.  
  - Example: If ice cream price increases from **RM 1.50 to RM 2.00**, quantity demanded decreases from **60 to 40 cones**.  
- **Shifts of the Demand Curve**:  
  - Caused by **changes in non-price determinants**.  
  - **Rightward Shift (Increase in Demand)**:  
    - Example: Income doubles (e.g., from RM 5,000 to RM 10,000), increasing demand for ice cream cones.  
    - **Graphical Impact**: Curve shifts right, indicating higher demand at each price.  
  - **Leftward Shift (Decrease in Demand)**:  
    - Example: Price of a related good (e.g., chocolates) drops, reducing ice cream demand.  
    - **Graphical Impact**: Curve shifts left, indicating lower demand at each price.  

### ðŸ©º Demand in Healthcare: Empirical Evidence  
#### ðŸ§ª Rand Health Insurance Experiments (1971â€“1982)  
- **Objective**: Investigate the effects of **cost-sharing** on:  
  - **Healthcare service utilization**.  
  - **Appropriateness and quality of care**.  
  - **Health outcomes**.  
- **Methodology**: Randomized controlled trial (RCT) involving over **2,700 households** in the USA, assigned to insurance plans with varying cost-sharing levels.  
- **Findings**:  
  - **Cost-sharing reduced utilization**, lowering healthcare costs.  
  - **No significant impact** on the **quality of care** received.  
  - **Health outcomes** were generally unaffected by cost-sharing.  
- **Table: Predicted Mean Annual Use of Medical Services by Plan**  

| **Plan**              | **Likelihood of Any Use (%)** | **One or More Admissions (%)** | **Medical Expenses (1984 $)** |
| --------------------- | ----------------------------- | ------------------------------ | ----------------------------- |
| Free                  | 86.7 (0.67)                   | 10.37 (0.420)                  | 777 (32.8)                    |
| Family Pay 25%        | 78.8 (0.99)                   | 8.83 (0.379)                   | 630 (29.0)                    |
| Family Pay 50%        | 74.3 (1.86)                   | 8.31 (0.400)                   | 583 (32.6)                    |
| Family Pay 95%        | 68.0 (1.48)                   | 7.75 (0.354)                   | 534 (27.4)                    |
| Individual Deductible | 72.6 (1.14)                   | 9.52 (0.529)                   | 623 (34.6)                    |

  - **Source**: Manning et al. (1987). *Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment*. *The American Economic Review*, 77, 251â€“277.  

#### ðŸŒ Madagascar Fee Exemption Study (2017)  
- **Context**: Evaluated the impact of **fee exemptions** for targeted medicines and services in rural Madagascar.  
- **Findings**:  
  - **Before Exemptions**: Fewer than **one-third** of people in need accessed healthcare due to point-of-service fees.  
  - **After Exemptions**:  
    - **65% increase** in overall healthcare use.  
    - **52% increase** for children under age five.  
    - **Over 25% increase** in maternity consultations.  
  - **Cost**: Sustained at an average direct cost of **US$0.60 per patient**.  
- **Implication**: *Removing user fees significantly increases healthcare access, supporting universal health coverage.*  
- **Source**: Garchitorena et al. (2017). *In Madagascar, Use of Health Care Services Increased When Fees Were Removed: Lessons For Universal Health Coverage*. *Health Affairs*, 36, 1443â€“1451.  

---

## ðŸ“ 4. Price Elasticity of Demand (PED)  

### ðŸ“‰ What is Price Elasticity?  
- **Definition**: *Price elasticity of demand (PED) measures the responsiveness of quantity demanded to a change in the price of a good or service.*  
- **Purpose**: Quantifies how sensitive consumers are to price changes.  
- **Formula**:  
  $$ \text{PED} = \frac{\% \text{ change in quantity demanded}}{\% \text{ change in price}} $$  
- **Example**: If price increases by **10%** and quantity demanded decreases by **20%**:  
  $$ \text{PED} = \frac{-20\%}{10\%} = -2 $$  

### ðŸ” Interpreting PED  
- **PED = -0.5 (Inelastic)**:  
  - Price increases by **10%**, quantity demanded decreases by **5%**.  
  - Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 95.  
  - For a **50%** price increase, quantity demanded decreases by **25%**.  
- **PED = -1.0 (Unit Elastic)**:  
  - Price increases by **10%**, quantity demanded decreases by **10%**.  
  - Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 90.  
  - For a **20%** price increase, quantity demanded decreases by **20%**.  
- **PED = -2.0 (Elastic)**:  
  - Price increases by **10%**, quantity demanded decreases by **20%**.  
  - Example: Price rises from RM 1.00 to RM 1.10, apple demand falls from 100 to 80.  
  - For a **20%** price increase, quantity demanded decreases by **40%**.  

### ðŸ“Š Types of Price Elasticity  
| **Elasticity Type**     | **PED Value** | **Description**                                             | **Examples**                                           |
| ----------------------- | ------------- | ----------------------------------------------------------- | ------------------------------------------------------ |
| **Elastic**             | > 1           | Large change in quantity demanded relative to price change. | Luxury cars, branded goods                             |
| **Inelastic**           | < 1           | Small change in quantity demanded relative to price change. | Essentials (salt, insulin)                             |
| **Unit Elastic**        | = 1           | Proportional change in quantity and price.                  | 20% price increase reduces demand by 20%               |
| **Perfectly Elastic**   | â†’ âˆž           | Slightest price increase reduces demand to zero.            | Perfect substitutes (e.g., identical products at RM 5) |
| **Perfectly Inelastic** | = 0           | Quantity demanded unchanged despite price changes.          | Life-saving drugs, salt (if affordable)                |
- **Perfectly Elastic Demand Curve**: Horizontal line at the market price (e.g., RM 5), where elasticity is **infinite**.  
- **Perfectly Inelastic Demand Curve**: Vertical line at a fixed quantity, where elasticity is **zero** (rare, e.g., essential medicines within affordability).  

### ðŸŒŸ Why Use Elasticity?  
- **Unit-Free Measure**: Enables comparison across markets without standardizing units.  
- **Applications**:  
  - Informs **pricing strategies** in healthcare and other sectors.  
  - Predicts consumer behavior in response to price changes.  

### ðŸŽ Examples of PED  
| **Good or Service** | **Demand Elasticity** |
| ------------------- | --------------------- |
| Apples (US)         | 1.15                  |
| Beef (UK)           | 1.45                  |
| Bread (UK)          | 0.26                  |
| Cigarettes (US)     | 0.30â€“0.50             |
- **Source**: Adapted from Folland, Goodman.  

### ðŸ©º PED in Healthcare  
| **Country**   | **Service Type**           | **Overall PED** | **Low Income** | **High Income** | **Source**                      |
| ------------- | -------------------------- | --------------- | -------------- | --------------- | ------------------------------- |
| Burkina Faso  | Public Provider (All Ages) | -0.79           | -1.44          | -0.12           | Sauerborn et al. (1994)         |
|               | Age 0â€“1                    | -3.64           |                |                 |                                 |
|               | Age 1â€“14                   | -1.73           |                |                 |                                 |
|               | Age 15+                    | -0.27           |                |                 |                                 |
| CÃ´te d'Ivoire | Health Clinic              |                 | -0.61          | -0.38           | Gertler and van der Gaag (1990) |
|               | Hospital Outpatient        |                 | -0.47          | -0.29           |                                 |
| Ethiopia      |                            | -0.50           |                |                 | Jimenez (1985)                  |
| Ghana         | Hospital Inpatient         | -1.82           |                |                 | Lavy and Quigley (1993)         |
|               | Hospital Outpatient        | -0.25           |                |                 |                                 |
|               | Dispensary                 | -0.34           |                |                 |                                 |
|               | Pharmacy                   | -0.20           |                |                 |                                 |
|               | Health Clinic              | -0.22           |                |                 |                                 |
| Kenya         | Government Provider        | -0.10           |                |                 | Mwabu et al. (1993)             |
|               | Mission Provider           | -1.57           |                |                 |                                 |
|               | Private Provider           | -1.94           |                |                 |                                 |
| Sudan         |                            | -0.37           |                |                 | Jimenez (1986)                  |
| Swaziland     |                            | -0.32           |                |                 | Yoder (1989)                    |
- **Source**: World Health Organization (2003). *Building on the User-fee Experience: The African Case*.  

### âš ï¸ Caution: Inelastic Demand in Healthcare  
- **Context**: Inelastic demand (PED < 1) suggests limited responsiveness to price changes, but this does not mean price increases are harmless.  
- **Table: Arc Price Elasticities in Burkina Faso (User Fee of US$0.57)**  

| **Subgroup**          | **Arc PED** | **% Change in Probability of Seeking Care** |
| --------------------- | ----------- | ------------------------------------------- |
| Total                 | -0.79       | -5.0%                                       |
| Age <1 year           | -3.64       | -26.0%                                      |
| Age 1â€“14 years        | -1.73       | -12.5%                                      |
| Age 15+ years         | -0.27       | -1.9%                                       |
| Income (1st Quartile) | -1.44       | -10.4%                                      |
| Income (2nd Quartile) | -1.21       | -8.7%                                       |
| Income (3rd Quartile) | -1.39       | -10.0%                                      |
| Income (4th Quartile) | -0.12       | -1.0%                                       |

  - **Source**: Sauerborn et al. (1994). *The Elasticity of Demand for Health Care in Burkina Faso*. *Health Policy and Planning*, 9, 185â€“192.  
- **Key Concerns**:  
  1. **Underuse in Developing Countries**: Healthcare is already **seriously underused** (e.g., 0.31 contacts per capita per year in rural Burkina Faso, mostly for serious illnesses). Price increases exacerbate untreated conditions.  
  2. **Frivolous Demand**: Raising prices to curb unnecessary demand is irrelevant in resource-constrained settings where demand is driven by **serious illnesses**.  
  3. **Equity Issues**: Price increases disproportionately affect **children** and **low-income groups**, reinforcing pre-existing inequities in access.  
  4. **Health Impacts on Children**: Reduced utilization leads to:  
     - **Progression of untreated illnesses**.  
     - **Missed immunizations**, creating **negative externalities** for the community.  

---

## ðŸ”„ 5. Cross Elasticity of Demand (CED)  

### ðŸ“ What is Cross Elasticity?  
- **Definition**: *Cross elasticity of demand (CED) measures the change in quantity demanded of one good in response to a change in the price of another good.*  
- **Formula**:  
  $$ \text{CED}_{AB} = \frac{\% \text{ change in quantity demanded of } A}{\% \text{ change in price of } B} $$  

### ðŸ” Interpreting CED  
- **Substitutes Example**: Apples (A) and oranges (B).  
  - **CED_{AO} = 0.5**:  
    - Orange price increases by **10%**, apple demand increases by **5%**.  
    - Example: Orange price rises from RM 1.00 to RM 1.10, apple demand rises from 100 to 105.  
- **Complements Example**: Ink cartridges (C) and printers (P).  
  - **CED_{CP} = -0.5**:  
    - Printer price increases by **10%**, cartridge demand decreases by **5%**.  
    - Example: Printer price rises from RM 1,000 to RM 1,100, cartridge demand falls from 100 to 95.  

### ðŸ›ï¸ Types of Goods  
| **Type**              | **CED Sign** | **Description**                    | **Examples**                                                                    |
| --------------------- | ------------ | ---------------------------------- | ------------------------------------------------------------------------------- |
| **Substitute Goods**  | Positive     | Goods that can replace each other. | Apples and oranges, Coke and Sprite, butter and margarine, cakes and chocolates |
| **Complement Goods**  | Negative     | Goods consumed together.           | Printers and cartridges, shavers and blades, glucose monitors and strips        |
| **Independent Goods** | Near Zero    | Goods with unrelated consumption.  | Flowers and radios, shoes and tables, durians and apples                        |

### ðŸ©º CED in Healthcare: Malaysia (1975 Study)  
- **Study**: Heller (1982). *A Model of the Demand for Medical and Health Services in Peninsular Malaysia*. *Social Science & Medicine*, 16, 267â€“284.  
- **Findings**:  
  - **Outpatient Care**: Highly **inelastic** to cash price (PED = -0.04).  
  - **Substitution Effects**:  
    - **Public vs. Private Clinics**: Cross elasticity of demand for public care due to private care price changes is **+0.15**.  
    - **Traditional vs. Western Care**: Cross elasticity of demand for traditional care due to western care price changes is **+0.05**.  
  - **Additional Insights**:  
    - Consumers are sensitive to **relative prices** of alternative healthcare sources.  
    - **Time costs** (travel and treatment time) reduce demand for services.  
  - **Note**: Data from 1975; interpret cautiously due to changes in healthcare systems.  

---

## ðŸ“¦ 6. Dynamics of Supply  

### ðŸ­ Understanding Supply  
- **Perspective**: From the **sellerâ€™s or firmâ€™s viewpoint**.  
- **Definition**: *Supply is the amount of a product that sellers are willing and able to sell over a period of time.*  
- **Key Determinants**:  
  - **Price** of the product (primary factor).  
  - **Non-price factors**: Costs of production (e.g., raw materials like sugar, eggs, milk), prices of related goods, technology, and preferences.  

### ðŸ¦ Supply Schedule for Ice Cream Cones  
| **Price per Cone (RM)** | **Quantity Supplied** |
| ----------------------- | --------------------- |
| 0.50                    | 0                     |
| 1.00                    | 100                   |
| 1.50                    | 200                   |
| 2.00                    | 300                   |
| 2.50                    | 400                   |
| 3.00                    | 500                   |
- **Observation**: As price increases, quantity supplied increases, reflecting the **law of supply**.  
- **Graphical Representation**: The **supply curve** slopes **upward**, showing a direct price-quantity relationship.  

### âš–ï¸ Law of Supply  
- **Statement**: *Other things being equal, when the price of a product rises, the quantity supplied rises, and when the price falls, the quantity supplied falls.*  
- **Intuition**: Higher prices incentivize producers to supply more, while lower prices reduce supply incentives.  

### ðŸ§® Supply Function  
- **Definition**: *The supply function shows the relationship between quantity supplied and various factors.*  
- **Mathematical Form**:  
  $$ Q_s = f(P, RP, C, T, \ldots) $$  
  - $Q_s$: Quantity supplied.  
  - $P$: Price of the good.  
  - $RP$: Prices of related goods.  
  - $C$: Costs of production (e.g., milk, sugar, eggs for ice cream).  
  - $T$: Technology or preferences.  
- **Example**: A decrease in **production costs** (e.g., price of sugar, eggs, and milk drops by half) shifts the supply curve **right**, increasing supply.  

### ðŸ”„ Shifts in Supply  
- **Shifts of the Supply Curve**:  
  - Caused by **changes in non-price factors**.  
  - **Rightward Shift (Increase in Supply)**:  
    - Example: Lower costs of raw materials (e.g., sugar, eggs, milk) increase ice cream supply.  
    - **Graphical Impact**: Curve shifts right, indicating higher supply at each price.  
  - **Leftward Shift (Decrease in Supply)**:  
    - Example: Higher ingredient costs or production disruptions reduce supply.  

---

## ðŸª 7. Understanding Markets  

### ðŸ“– What is a Market?  
- **Definition**: *A market for any good or service consists of all the buyers and sellers of that good or service.*  
- **Interactions**:  
  - **Buyers**: Determine **quantity demanded** based on prices.  
  - **Sellers (Firms)**: Determine **quantity supplied/produced** based on prices.  
  - **Outcome**: Prices adjust to balance supply and demand.  

### ðŸ” Characteristics of Markets  
- **Number of Sellers**: Ranges from one (monopoly) to many (perfect competition).  
- **Product Differentiation**: Products may be **identical** (e.g., ice cream cones from different vendors) or **differentiated** (e.g., branded ice creams).  
- **Entry/Exit Barriers**: Ease or difficulty for new firms to enter or leave the market.  

### ðŸ“Š Types of Market Structures  
| **Structure**                | **Number of Firms** | **Product Type**       | **Entry/Exit**  | **Example**              |
| ---------------------------- | ------------------- | ---------------------- | --------------- | ------------------------ |
| **Perfect Competition**      | Many                | Identical              | Free            | Agricultural markets     |
| **Monopolistic Competition** | Many                | Differentiated         | Relatively Free | Restaurants              |
| **Oligopoly**                | Few                 | Similar/Differentiated | Moderate        | Telecommunications       |
| **Monopoly**                 | One                 | Unique                 | Restricted      | Utility companies        |
| **Monopsony**                | One buyer           | Multiple suppliers     | Varies          | Government as sole buyer |

---

## ðŸŒŸ 8. Perfectly Competitive Market  

### ðŸ“‹ Characteristics  
- **Many Small Firms and Customers**: No single entity can influence the market price.  
- **Identical Products**: Customers are indifferent to which firm they buy from (e.g., identical ice cream cones).  
- **Freedom of Entry and Exit**: No barriers prevent firms from entering or leaving the market.  
- **Perfect Information**: Firms and customers are fully informed about products and prices.  

### â“ Why Study Perfect Competition?  
- **Efficiency**: *Under perfect competition, the market mechanism performs best.*  
  - **Adam Smith**: Perfectly competitive firms use **societyâ€™s scarce resources** with **maximum efficiency**.  
  - **Friedrich Engels**: Ensures production aligns with **customer preferences** in variety and quantity.  
- **Benchmark**: Serves as an ideal model for understanding market efficiency, though rare in practice.  

### ðŸ“ˆ Supply Curve in Perfect Competition  
- **Horizontal Supply Curve**:  
  - A firmâ€™s output is so **small** it cannot affect the **market price**.  
  - Firms can sell as much as they want at the **prevailing market price**.  
- **Graphical Representation**:  
  - **Market Supply Curve**: Upward sloping, reflecting total supply.  
  - **Firmâ€™s Supply Curve**: Horizontal at the market price, as firms are **price takers**.  
- **Implication**: Firms accept the market price without influence.  

---

## âš–ï¸ 9. Supply and Demand Equilibrium  

### ðŸ“– What is Equilibrium?  
- **Definition**: *Equilibrium is a situation where the price reaches a level where quantity supplied equals quantity demanded.*  
- **Mathematical Condition**:  
  $$ Q_d = Q_s $$  
- **Outcome**: No **shortages** or **surpluses** in a competitive market; price stabilizes at the **equilibrium price**.  

### ðŸ¦ Equilibrium Example: Ice Cream Cone Market  
- **Equilibrium Analysis**:  

| **Price (RM)** | **Quantity Demanded** | **Quantity Supplied** | **Market State** |
| -------------- | --------------------- | --------------------- | ---------------- |
| 2.00           | 300                   | 300                   | Equilibrium      |
| 2.50           | 200                   | 400                   | Surplus (200)    |
| 1.50           | 400                   | 200                   | Shortage (200)   |

- **Scenarios**:  
  - **Price = RM 2.50**: Excess supply (**surplus of 200 cones**) leads to price reduction.  
  - **Price = RM 1.50**: Excess demand (**shortage of 200 cones**) leads to price increase.  
  - **Price = RM 2.00**: Market clears with **equilibrium quantity of 300 cones**.  

### ðŸ”„ Effects of Shifts on Equilibrium  
- **Increase in Supply** (rightward shift):  
  - **Lower equilibrium price**, **higher equilibrium quantity**.  
  - Example: Cheaper raw materials (e.g., sugar, eggs, milk) increase ice cream supply, shifting the supply curve right.  
- **Increase in Demand** (rightward shift):  
  - **Higher equilibrium price**, **higher equilibrium quantity**.  
  - Example: Rising consumer income boosts ice cream demand, shifting the demand curve right.  

---

## ðŸ§¾ 10. Recap and Key Principles  

### ðŸ“‹ Core Economic Laws  
- **Law of Demand**: *When the price falls, the quantity demanded rises.*  
- **Law of Supply**: *When the price increases, the quantity supplied rises.*  

### ðŸ§  Rational Decision-Making  
- **Rational Person**: Aims to **maximize utility** (satisfaction) within **limited resources**.  
- **Decision Process**: Balances **costs** (including **opportunity costs**) and **benefits**.  
- **Marginal Analysis**: Focuses on **incremental costs and benefits**, foundational for **economic evaluations in healthcare**.  

### ðŸŒŸ Key Takeaways  
- **Demand and Supply**: Driven by price and non-price factors, visualized through **curves** and **functions**.  
- **Elasticity**: Measures responsiveness, critical for pricing and policy in healthcare.  
- **Perfect Competition**: Ideal market structure for **efficiency**, serving as a benchmark for real-world markets.  
- **Equilibrium**: Balances supply and demand, ensuring no shortages or surpluses.  

---

# HE 3 - Demand for Health and Health Care  

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Dr Ainol Haniza Kherul Anuwar**  
**DDS (UGM), MCOH (Distinction) (Malaya), DrDPH (Malaya)**  
**Department of Community Oral Health & Clinical Prevention, Faculty of Dentistry, Universiti Malaya**  
**Credit: Prof Dr Ng Chiu Wan, Department of Social & Preventive Medicine, Faculty of Medicine, Universiti Malaya**  

---

## ðŸ“š 1. Introduction and Learning Outcomes  

**Health Economics** investigates how individuals demand **health** and **healthcare**, influenced by economic principles such as **supply**, **demand**, and **market structures**. This lecture explores the production of health, the theoretical and empirical aspects of demand, and the impact of payment mechanisms and insurance on healthcare systems, emphasizing their role in shaping provider and patient behavior.

### ðŸ” Revision of Foundational Concepts  
- **Law of Demand**: *When the price falls, the quantity demanded rises.*  
- **Law of Supply**: *When the price increases, the quantity supplied rises.*  
- **Perfectly Competitive Market**: *Equilibrium occurs when the quantity of goods supplied equals the quantity demanded.*  

### ðŸŽ¯ Learning Outcomes  
By the end of this unit, students will be able to:  
- **Understand** the distinction between **demand for health** and **demand for healthcare** ðŸ¥.  
- **Explain** the impact of **provider payment mechanisms** on provider behavior ðŸ’°.  
- **Comprehend** the concept of **insurance** and its role in healthcare systems ðŸ›¡ï¸.  
- **Discuss** **moral hazard** and its relation to third-party payers ðŸ¤”.  
- **Describe** strategies to **influence demand for healthcare** ðŸ“Š.  

---

## ðŸ—‚ï¸ 2. Lecture Contents  

The lecture is organized into three core sections, reflecting a central concern for **health economists** and **public policy**:  
1. **Production of Health**: Examines the inputs and outputs in health production âš™ï¸.  
2. **Demand for Health & Healthcare**: Analyzes theoretical frameworks and empirical evidence â¤ï¸.  
3. **Influencing Demand for Healthcare**: Covers:  
   - **Provider payment mechanisms** and their incentives on providers ðŸ’³.  
   - **Moral hazard** associated with third-party payers âš ï¸.  

---

## ðŸ©º 3. Production of Health  

### ðŸ“– Why Study Health Production?  
- **Definition**: *Health production involves transforming inputs (e.g., healthcare, nutrition) into outputs (e.g., improved health status).*  
- **Significance**:  
  - Lies at the **heart of health economics and public policy**.  
  - Guides **efficient allocation** of **scarce resources**.  
  - Informs selection of **optimal production pathways**.  
- **Key Questions**:  
  1. What factors influence the **production of health**?  
  2. What is the **contribution of healthcare** to health production?  
  3. Has this contribution **changed over time**?  

### ðŸ“š McKeownâ€™s Thesis  
- **Context**: Thomas McKeown analyzed the **dramatic population growth** in England and Wales from around 1770 to the 20th century.  
- **Source**: McKeown, T. (1967). *The Modern Rise of Population*. New York: Academic Press.  
- **Key Findings**:  
  - **Population Growth**: Primarily due to a **decline in mortality** rather than in-migration or increased fertility rates ðŸš¼.  
  - **Mortality Decline**: Most prominent for **infectious diseases**, especially **airborne infections** (e.g., tuberculosis, bronchitis, pneumonia, influenza) ðŸ˜·.  
  - **Timeline**:  
    - 1838â€“1970: Decline in **tuberculosis (TB) mortality** in England and Wales.  
    - 1882: Koch identifies the **TB bacillus**.  
    - 1940s: Introduction of **streptomycin** (antibiotic for TB).  
    - 1953: **BCG immunization** for all children.  
  - **Conclusions**:  
    - **Medical Technology**: Played a **minimal role** in mortality decline ðŸ©º.  
    - **Public Health Measures**: Important but not the major contributor (e.g., immunizations, clean water supplies, sewage systems) ðŸ’‰.  
    - **Rising Standards of Living**: The **most important factor**, enhancing **nutritional status** that led to increased **disease resistance** ðŸ½ï¸.  

#### **Table: McKeownâ€™s Thesis Summary**  
| **Insight**                   | **Finding**                                                                 |
|-------------------------------|-----------------------------------------------------------------------------|
| **Cause of Population Growth**| Decline in mortality, not increased births or migration                     |
| **Cause of Mortality Decline**| Reduced airborne infectious diseases (e.g., TB, pneumonia)                 |
| **Role of Medical Technology**| Minimal                                                                    |
| **Role of Public Health**     | Important but not the primary contributor                                  |
| **Key Driver**                | Improved living standards, especially nutrition, enhancing disease resistance|

### ðŸ“ˆ Contribution of Healthcare to Health  
- **Total Contribution**:  
  - History shows that over long periods, **curative medical care** may not have been the most significant factor in health improvements.  
- **Marginal Contribution**:  
  - Recent evidence highlights that **adequate access to healthcare** significantly extends life expectancy, particularly in older populations.  
  - **Example (China Study)**:  
    - At age 65: **Adequate access to healthcare** increased life expectancy by approximately **2.0â€“2.5 years** in men and women, across urban-rural areas, compared to those with inadequate access ðŸ§“.  
    - At age 85: The corresponding increase was **1.0â€“1.2 years**.  
    - **Source**: Hao, L., et al. (2020). *Adequate access to healthcare and added life expectancy among older adults in China*. *BMC Geriatrics*, 20(1), 129. https://doi.org/10.1186/s12877-020-01524-9.  
- **Conclusion**: The **relationship between consumption of healthcare and improved health** leads to the **demand for healthcare** ðŸ”„.  

---

## â¤ï¸ 4. Demand for Health and Healthcare  

### âš–ï¸ Rational Decision-Making  
- **Main Assumptions**:  
  - Consumers have the **ability to judge** based on **information** about:  
    - **Costs of consumption** (e.g., price, time, and other costs).  
    - **Benefits of consumption** (e.g., health improvements).  
  - **Costs and benefits** are borne by the consumer.  
  - Consumers make decisions to:  
    - **Consume or not consume** a service.  
    - If consuming, decide **how much to consume**.  
- **Decision Logic**:  
  - **Axiom of Completeness**: Consumers can **order preferences** ðŸ§¾.  
  - **Axiom of Transitivity**: If bundle $A$ is preferred to $B$, and $B$ to $C$, then $A$ is preferred to $C$.  
  - **Axiom of Selection**: Consumers choose the **most preferred state**.  
- **Expected Utility Theory**:  
  - Consumers can judge **costs and benefits** under **conditions of uncertainty** using the concept of **risk**.  
  - Only **consequences (outcomes)** matter, not the process of decision-making.  
  - Assumes **separation of consumption and production**.  

### ðŸš¨ Special Nature of Healthcare  
- **Unique Characteristics**:  
  - **Health information is highly technical**, making it difficult for consumers to judge **costs and benefits**.  
  - Consumers may **relinquish decisions** to **healthcare professionals**.  
  - **Healthcare professionals (suppliers)** can **directly or indirectly influence** the consumption (demand) of healthcare.  
  - **Supplier and consumer roles** cannot be fully separated.  
- **Externalities in Health**:  
  - **Costs and benefits** are not only borne by the consumer but also affect **society**.  
  - **Resultant utility** extends beyond consumption of care to include:  
    - **Fair distribution** (equity).  
    - **Passing on difficult decision-making** to professionals.  

### ðŸ“œ Grossmanâ€™s Theory of Health Demand  
- **Source**: Grossman, M. (1972). *On the Concept of Health Capital and the Demand for Health*. *Journal of Political Economy*, 80, 223â€“255.  
- **Core Proposition**:  
  - **Health** is a **durable capital stock** that produces an output of **healthy time** ðŸ‘¤.  
  - Individuals inherit an **initial stock of health** that:  
    - **Depreciates** with age (potentially at a non-constant rate).  
    - Can be **increased** by investment (e.g., healthcare, lifestyle choices).  
- **Key Concepts**:  
  - Individuals act as both **consumers** and **producers** of health.  
  - The **idea of the individual as a producer** concerns how they **allocate resources** (time and money) to produce health.  
  - **Investing in human capital** (health and education) improves outcomes in:  
    - **Market sectors** (e.g., work productivity).  
    - **Non-market sectors** (e.g., household roles).  
  - **Shadow Price of Health**: Depends on variables beyond medical care costs, such as:  
    - **Age**: Rises if the **depreciation rate** of health increases over the life cycle.  
    - **Education**: Falls if more educated people are **more efficient producers** of health.  
  - **Implication**: An increase in the shadow price may **simultaneously reduce the quantity of health demanded** and **increase the quantity of medical care demanded**.  

#### **Key Principles of Demand**  
- **Derived Demand**:  
  - **Demand for healthcare** is derived from the **demand for health** ðŸ’¡.  
  - **Demand for health** is derived from the **demand for utility**.  
- **Active Role**:  
  - Individuals are **not passive consumers** but **active producers** who spend **time and money** on the production of health.  
- **Health as Capital**:  
  - Health **lasts over time periods**, **depreciates**, and can be analyzed as a **capital good** ðŸ”„.  

---

## ðŸ‡²ðŸ‡¾ 5. Malaysian Healthcare Demand Studies  

### ðŸ“– Overview  
Empirical studies in Malaysia provide critical insights into healthcare demand, highlighting the influence of **income**, **age**, **ethnicity**, and **accessibility** on health-seeking behavior.

#### **Peter Hellerâ€™s Classic Study (1975)**  
- **Source**: Heller, P. S. (1982). *A model of the demand for medical and health services in Peninsular Malaysia*. *Social Science & Medicine*, 16, 267â€“284.  
- **Data**: From a **1975 household survey** in Peninsular Malaysia.  
- **Findings**:  
  - **Demand for outpatient and inpatient care** is **highly inelastic** to **cash price**, **income**, or **time costs**.  
  - As **income increases**, households:  
    - Shift demand from **traditional practitioners** to **modern medical practitioners**.  
    - Shift demand from **public clinics** to **private clinics**.  
    - Shift demand from **home deliveries** to **hospital deliveries**.  
    - Increase demand for **prenatal care** (preventive care).  
  - **Findings did not reveal a U-shaped relationship** between age and demand for outpatient care.  
  - **Findings partially attributable** to accessibility to **subsidized public care**.  

#### **Rozita et al.â€™s Study (1996)**  
- **Source**: Rozita, H. H., Sarawak, S., Oostendorp, R., & Zulkarnain, A. K. (2000). *Health Care Demand Analysis: Models and Policy Simulation for Malaysia*. International Conference on Evidence-based Practice: Towards Evidence-based Policymaking in Health Sector Development, Kuala Lumpur, Malaysia.  
- **Data**: From the 2nd **National Health and Morbidity Survey (NHMS)** conducted in 1996.  
- **Findings**:  
  - **Higher outpatient demand** among the **young** and **older persons**, showing a **U-shaped age demand pattern** ðŸ“Š.  
  - **No gender differences** in demand.  
  - **Distance** was **not a deterrent** to utilization of services.  
  - **Chinese** households were **more likely to choose private care**.  
  - **Households with higher income** demonstrated a **preference for private healthcare**.  

#### **Health Policy Research Associates (HPRA) Study**  
- **Source**: Health Policy Research Associates, Institute for Health Systems Research & Institute for Health Policy. (2013). *Malaysia Health Care Demand Analysis: Inequalities in Healthcare Demand & Simulation of Trends and Impact of Potential Changes in Healthcare Spending*. Kuala Lumpur: Institute for Health Systems Research.  
- **Data**: From NHMS 1986, 1996, 2006, and 2011, adjusted with **OECD database**.  
- **Key Insight**: Revealed **significant differences in service provision** between **public and private sectors**.  

#### **Malaysian Health Systems Research**  
- **Source**: Ministry of Health Malaysia & Harvard T.H. Chan School of Public Health. (2016). *Malaysian Health Systems Research Volume 1: Contextual Analysis of the Malaysian Health System*. Ministry of Health Malaysia.  
- **Contribution**: Provides a comprehensive analysis of the Malaysian health system, reinforcing findings on demand patterns and sectoral differences.  

#### **Table: Summary Statistics on Financing and Utilization of Primary Healthcare (2013â€“2015)**  
| **Indicator**                                                                       | **Public Facilities**                                                         | **Private Clinics (includes primary care GPs and specialist clinics)** |
| ----------------------------------------------------------------------------------- | ----------------------------------------------------------------------------- | ---------------------------------------------------------------------- |
| **Expenditure, as % of primary healthcare expenditure (2013)**                      | 35%                                                                           | 65%                                                                    |
| **Utilization rate of outpatient service, visits per person per year (2015)**       | 2.0                                                                           | 1.3                                                                    |
| **Utilization of outpatient services, as % of total outpatient utilization (2015)** | 60%                                                                           | 40%                                                                    |
| **Facilities, as % of clinics (2014, HIC)**                                         | 31%                                                                           | 69%                                                                    |
| **Doctors, # (2014)**                                                               | 3,132 MOs, excluding FMS                                                      | N/A                                                                    |
| **Top 4 reasons for encounters (NMCS 2012 Primary healthcare)**                     | Hypertension, diabetes, lipid disorder, pregnancy (chronic illnesses and MCH) | Fever, cough, abdominal pain, diarrhea (acute conditions/symptoms)     |
- **Sources**: MNHA, NHMS 2015, CRC (June 2015), HIC, BPKK, NMCS 2012 Primary healthcare.  

---

## âš™ï¸ 6. Influencing Demand for Healthcare  

### ðŸ“‹ Overview  
Demand for healthcare can be influenced through:  
- **Supply-Side Measures**: Factors related to **providers of care**, such as the **number and distribution of facilities** and **doctors** ðŸ¥.  
- **Demand-Side Measures**: Factors related to **individual choices**, such as **disposable income**, **education**, and **preferences** ðŸ›ï¸.  

### ðŸ©º Role of Payment Mechanisms  
- **Key Idea**: *Demand for healthcare can be affected by the manner in which healthcare services are paid.*  
- **Mechanisms**:  
  - **Supply-Side Measures**: Changing **provider behavior** through different **payment mechanisms**.  
  - **Demand-Side Measures**: Changing **patient behavior** through the impact of **third-party payers** such as insurance companies.  

---

## ðŸ’° 7. Provider Payment Mechanisms  

### ðŸ“– Overview  
Provider payment mechanisms vary by the **unit of payment**, ranging from **simple** (e.g., payment per procedure) to **complex/aggregated** (e.g., payment for a yearâ€™s services). These methods impact **cost**, **quality**, and **quantity of care** for **doctors** and **hospitals**.

#### **Fee-for-Service (FFS)**  
- **Definition**: *Provider receives a fee for every service given.*  
- **Example**: If a patient is seen by a GP, has a chest X-ray, and receives an injection, the GP receives a **consultation fee**, a **fee for the CXR**, and a **fee for the injection** ðŸ©º.  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for doctors and hospitals.  
- **Incentives**:  
  - **Beneficial**:  
    - Patients are likely to receive **optimal level and quality of care**.  
    - Patients requiring **complex treatment** are not likely to be denied care.  
  - **Adverse**:  
    - **Provider-Induced Demand (PID)**: Providers may over-provide services to increase income due to financial incentives ðŸ¤.  
- **Principal-Agent Relationship**:  
  - **Principal**: Patient.  
  - **Agent**: Provider.  
  - **Principal-Agent Problem**: Due to **asymmetry of information**, the principal may not be able to ensure that the agent is acting in their **best interest**, especially if provision is linked to increased income.  

#### **Per Diem Payment**  
- **Definition**: *Hospital receives one fixed payment that covers all services delivered to one patient for one day.*  
- **Example**: Mr. ABC is admitted for pneumonia, and Mr. DEF is admitted for backache; both are discharged after one day. The hospital receives the **same payment** for both, regardless of the type and quantity of services received ðŸ›ï¸.  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for hospitals.  
- **Incentives**:  
  - **Providers have incentives to provide less in a day**, as payment is the same regardless of the quantity or quality of services provided.  
  - **May prolong the period of hospitalization**, as longer admissions lead to more payments, potentially driving up **costs**.  
  - **Quality of care may be affected** due to reduced services per day.  

#### **Case-Based Payment**  
- **Definition**: *Provider receives a predetermined fee that covers all services per case or episode of illness, which may require more than a dayâ€™s treatment.*  
- **Examples**: **Maternity package** (bundling ante-, intra-, and postpartum care), **Diagnosis-Related Groups (DRGs)** ðŸ§¾.  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for hospitals.  
- **Incentives**:  
  - **Providers have a strong incentive to contain costs per case**.  
  - **Over-treatment and unnecessary interventions** are unlikely.  
  - **Patients potentially may receive less than optimal care**, as providers may reduce the **quantity and quality of treatment** since payment is based on diagnosis.  

#### **Capitation**  
- **Definition**: *Provider receives a fee for all services provided to one patient, usually for a period of time (e.g., the entire year).*  
- **Example**: A GP in the United Kingdom receives one fee from the NHS to look after all the healthcare needs of one patient ðŸ‘¨â€âš•ï¸.  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for doctors.  
- **Incentives**:  
  - **Providers have a strong incentive to contain costs per case**.  
  - **Over-treatment and unnecessary interventions** are unlikely.  
  - **Adverse selection of patients**: Doctors may turn away **sick patients** who cost more to treat.  

#### **Salary**  
- **Definition**: *Provider receives a fixed fee for all the services provided in one month, regardless of the number of patients or services provided.*  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for doctors.  
- **Incentives**:  
  - **Patients are unlikely to be denied needed care**.  
  - **Doctors lack incentive to contain costs**, which may drive up costs.  
  - **Lack incentive to be productive**, potentially lowering efficiency ðŸ“….  

#### **Global Budget**  
- **Definition**: *Hospital receives a fixed budget for all the services provided in one year, regardless of the number of patients or services provided.*  
- **Potential Impact**: Affects **cost**, **quality**, and **quantity of care** for hospitals.  
- **Incentives**:  
  - **Hospital has a strong incentive to contain costs**.  
  - **Controls behavior of doctors** to align with budget constraints.  
  - **May impact the quality of care**, potentially leading to rationing or reduced access ðŸ¢.  

#### **Table: Provider Payment Mechanisms**  
| **Payment Method**  | **Unit of Payment**    | **Pros**                                 | **Cons**                          |
| ------------------- | ---------------------- | ---------------------------------------- | --------------------------------- |
| **Fee-for-Service** | Per visit/procedure    | Optimal care, no denial of complex cases | Provider-induced demand           |
| **Per Diem**        | Per day                | Efficiency per day                       | Longer stays, reduced quality     |
| **Case-Based**      | Per case/diagnosis     | Cost containment, less over-treatment    | Under-treatment, lower quality    |
| **Capitation**      | Per patient per period | Cost containment, less over-treatment    | Adverse selection                 |
| **Salary**          | Per month              | No denial of care                        | No cost control, low productivity |
| **Global Budget**   | Annual allocation      | Cost control, system planning            | Rationing, quality concerns       |

---

## ðŸ›¡ï¸ 8. Insurance and Moral Hazard  

### ðŸ“– What is Insurance?  
- **Definition**: *Insurance is a prepayment into a common fund that pays providers for future healthcare needs, protecting the patient against financial loss.*  
- **Key Feature**: **Insured individuals** do not bear the full **financial risk** if they fall ill and require healthcare, as they **do not need to pay more** at the point of service ðŸ’¸.  

### ðŸ’° Financial Risk and Third-Party Payers  
- **Effect of Third-Party Payers**:  
  - **Insured do not pay directly for the full cost of care**, with costs covered by **insurers** or other payers.  
  - This reduces **financial barriers**, leading to **increased demand** and **higher system costs**.  
- **Moral Hazard Effect**: A significant consequence of third-party payment systems.  

### âš ï¸ Moral Hazard  
- **Definition**: *Moral hazard occurs when a party insulated from risk behaves differently than it would behave if it were fully exposed to the risk.*  
- **Applying to Health Insurance**:  
  - The **existence of insurance cover** changes the behavior of the insured because they no longer have to bear the **full financial risk** when consuming healthcare services.  
  - In most instances, this **increases the use of healthcare services** and thus **increases costs** â—.  

### ðŸ”„ Mechanisms of Moral Hazard  
- **Change of Behavior**:  
  - Insured individuals may indulge in **risky behaviors** (e.g., drink driving, risky sexual behaviors).  
- **Information Asymmetry**:  
  - Insured may withhold information on **past medical conditions** (e.g., past history of myocardial infarct).  
- **Decreased Payment at Point of Usage**:  
  - Since **payment is made by insurers** and not patients, patients have **no incentives to control use and control costs**.  
  - This is **less likely to apply when demand is inelastic** (e.g., essential treatments).  

### ðŸ“‰ Moral Hazard and Demand Types  
- **Inelastic Demand**:  
  - **Example**: Insulin for treatment of **Type 1 Diabetes Mellitus**.  
  - **Quantity does not change with price**, leading to **no appreciable moral hazard**.  
- **Elastic Demand**:  
  - **Example**: GP visits for a fever.  
  - **Without Insurance**:  
    - Patients need to pay **price $P_1$**, resulting in **demand of $Q_1$ visits**.  
  - **With Insurance**:  
    - **No payment up front** (marginal price = 0, as the price is paid by the insurer).  
    - **Price = 0**, increasing **demand to $Q_2$ visits**.  
  - **Graphical Representation**:  
    - The demand curve shifts right as the effective price drops to zero, reflecting increased consumption due to reduced cost barriers.  

#### **Table: Elastic vs. Inelastic Demand**  
| **Demand Type** | **Example**                          | **Moral Hazard Risk** |
| --------------- | ------------------------------------ | --------------------- |
| **Inelastic**   | Insulin for Type 1 Diabetes Mellitus | Low                   |
| **Elastic**     | GP visits for mild fever             | High                  |
- **Note**: Elastic demand is **more sensitive to price changes**, making it more prone to **moral hazard**.  

### ðŸ“‹ Terminology in Health Insurance  
| **Term**         | **Definition**                                                                                                             |
| ---------------- | -------------------------------------------------------------------------------------------------------------------------- |
| **Premium**      | Amount paid for specified coverage.                                                                                        |
| **Coverage**     | Specified benefits that can be obtained.                                                                                   |
| **Cost Sharing** | Sharing of costs between insured and insurer.                                                                              |
| **Deductible**   | Shared payment specified as fixed amounts paid by insured over a period of time (e.g., a year) before insurer cost-shares. |
| **Coinsurance**  | Shared payment specified as a percentage of costs.                                                                         |
| **Copayments**   | Fixed amount needed to be paid each time before insured receives care.                                                     |

### ðŸŒ Other Third-Party Payers  
- **Employers**:  
  - Employees may be covered under **employment benefits**.  
  - Companies may **self-insure** or **purchase insurance coverage**.  
  - **Similar moral hazard issues** as direct health insurance apply ðŸ¢.  
- **Government**:  
  - Provides **public provision and financing of healthcare**.  
  - **Moral hazard issues still exist** due to reduced patient costs at the point of service ðŸ›ï¸.  

### ðŸ› ï¸ Mechanisms to Overcome Moral Hazard  
- **Problem**: **Moral hazard will lead to higher insurance pay-outs** due to increased healthcare utilization.  
- **Solution**: Ensure that **care is no longer free at the point of usage** to align patient incentives with cost control.  
- **Mechanisms**:  
  - **Copayments**: Fixed amount paid per visit.  
  - **Coinsurance**: Percentage-based cost sharing (e.g., 20% of costs).  
  - **Deductibles**: Fixed amounts paid by the insured over a period before insurer cost-shares.  
- **Purpose**: Encourage **responsible consumption** and reduce overuse ðŸ”.  

---

## âœ… 9. Lecture Recap  

| **Theme**                    | **Key Takeaway**                                                                                            |
| ---------------------------- | ----------------------------------------------------------------------------------------------------------- |
| **Demand for Health**        | Derived from the demand for utility, with health as a durable capital good ðŸ’¡.                              |
| **Rational Decision-Making** | Consumers weigh costs vs. benefits, but healthcareâ€™s technical nature complicates choices ðŸ§ .               |
| **Nature of Healthcare**     | Characterized by asymmetric information, externalities, and provider influence ðŸ¥.                          |
| **Malaysian Studies**        | Income, age, and ethnicity shape health-seeking patterns, with significant public-private differences ðŸ‡²ðŸ‡¾. |
| **Payment Mechanisms**       | Influence cost, quality, and quantity of care through provider incentives ðŸ’°.                               |
| **Moral Hazard**             | Third-party payers distort consumer behavior, increasing healthcare use and costs âš ï¸.                       |
| **Insurance**                | Reduces financial risk but may drive demand and costs ðŸ›¡ï¸.                                                  |
| **Cost Control Mechanisms**  | Copayments, coinsurance, and deductibles mitigate overuse ðŸ”.                                               |

---

# HE 4 - Financing Health Care  

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Prof Ng Chiu Wan**  
**Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  

---

## ðŸ“š 1. Introduction to Health Care Financing  

**Health care financing** ensures resources are mobilized, pooled, and allocated to deliver care while protecting individuals from financial hardship. This lecture, delivered on **17th April 2025**, explores the structure of **health systems**, the mechanics of **health financing systems**, various **financing modalities**, and **National Health Accounts (NHAs)** to track expenditures.

### ðŸŽ¯ Lecture Objectives  
- Define a **health system** and its functions.  
- Explain the components of a **health financing system**.  
- Examine **financing options**: general taxation, social insurance, private insurance, out-of-pocket payments, Medical Savings Accounts, and Community Health Financing.  
- Understand **National Health Accounts** for analyzing health expenditure flows.  

### ðŸ“‹ Lecture Contents  
- What is a **health system**?  
- What is a **health financing system**?  
- Main options in **health financing**:  
  - General taxation  
  - Social insurance  
  - Private insurance  
  - Out-of-pocket (OOP) payments  
  - Others (Medical Savings Accounts, Community Health Financing)  
- What are **National Health Accounts**?  

---

## ðŸ©º 2. Understanding Health Systems  

### ðŸ“– What is a Health System?  
- **Health Action**: *Any set of activities whose primary intent is to improve or maintain health.*  
- **Health System**: *The set of resources, actors, and institutions involved in the financing, regulation, and provision of health actions.*  
  - **Source**: Murray, C. J. & Frenk, J. (2000). *A framework for assessing the performance of health systems*. *Bulletin of the World Health Organization*, 78, 717â€“31.  

### âš™ï¸ Functions of a Health System  
- **Two Main Components**:  
  - **Health Care Delivery System**:  
    - Comprises the **organization of facilities and personnel** to deliver healthcare to the public.  
    - Traditionally divided into **public and private sectors**, but boundaries are now **less distinct**.  
  - **Health Financing System**:  
    - Supports delivery through **resource mobilization** and **allocation**.  
- **Interlinkage**: Components are **closely interlinked** and require a **holistic approach** for effective performance.  
- **Source**: Murray, C. J. & Frenk, J. (2000). *A framework for assessing healthcare systems*. *Bulletin of the World Health Organization*, 78(6), 717â€“31.  

### ðŸŽ¯ Objectives of a Health System  
- **Fundamental Goals**:  
  - **Improving the health** of the populations served.  
  - **Responding to peopleâ€™s expectations**.  
  - **Providing financial protection** against the costs of ill-health.  
- **Source**: World Health Organization (2000). *World Health Report 2000. Health Systems: Improving Performance*. Geneva: WHO.  

---

## ðŸ›¡ï¸ 3. Financial Risk Protection in Universal Health Coverage  

### ðŸ“‹ Importance of Financial Protection  
- **Core of Universal Health Coverage (UHC)**: *Financial protection ensures direct payments for health services do not expose people to financial hardship or threaten living standards.*  
- **Goal**: Achieve **equity** and **sustainability** in healthcare access.  
- **Source**: World Health Organization (2010). *World Health Report 2010. Financing for universal coverage*. Geneva: WHO.  

### ðŸ”„ Risk Pooling and Prepayment  
- **Definition**: *Mechanisms to spread the financial risk of healthcare costs across a population.*  
- **Mechanism**:  
  - **Prepayment**: Funds are collected in advance (e.g., taxes, insurance premiums).  
  - **Risk Pooling**: Risks are shared so no individual bears the full cost of unexpected health expenses.  
- **Key Idea**: Essential for reducing **financial barriers** and ensuring **equitable access**.  
- **Source**: World Health Organization (2010). *World Health Report 2010. Financing for universal coverage*. Geneva: WHO.  

---

## ðŸ’° 4. Components of Health Financing Systems  

### ðŸ“– What is Health Care Financing?  
- **Definition**: *The mobilization, pooling, and allocation of funds to cover healthcare costs.*  
- **Key Components**:  

| **Component**          | **Description**                                                                 |
|------------------------|--------------------------------------------------------------------------------|
| **Revenue Collection** | Mobilizing funds from households, organizations, governments, and donors.      |
| **Fund Pooling**       | Accumulating and managing funds to share financial risks across contributors.   |
| **Purchasing**         | Allocating funds to providers, either passively or strategically, to deliver care. |

### ðŸ¦ Revenue Collection  
- **Process**: *Collecting funds from various sources to finance healthcare.*  
- **Examples**:  
  - **Taxation**: Direct (e.g., income tax) and indirect (e.g., sales tax).  
  - **Insurance**: Premiums for social or private insurance.  
  - **Direct Contributions**: Out-of-pocket (OOP) payments by households.  
  - **Donations**: External or charitable contributions.  

### ðŸ” Fund Pooling  
- **Definition**: *Accumulation and management of revenue to ensure sharing of financial risk.*  
- **Key Feature**: *The risk of paying for healthcare services is shared by all in the pool, not just the contributor.*  
- **Variation**:  
  - **Taxation-based Pooling**: Offers **high risk sharing** (e.g., universal coverage systems).  
  - **OOP Payments**: Provide **no pooling**, as individuals bear full costs.  
- **Consideration**: Benefits of **single vs. multiple funds** in pooling efficiency.  

### ðŸ§¾ Purchasing Health Services  
- **Definition**: *Allocation of funds to facilities/providers to deliver healthcare.*  
- **Approaches**:  

| **Type**       | **Description**                                                                 |
|----------------|--------------------------------------------------------------------------------|
| **Passive**    | Paying providers based on submitted bills with little oversight (e.g., fee-for-service). |
| **Strategic**  | Selective contracting, performance-linked payments, and quality monitoring to maximize system performance. |

- **Incentives**: Need to be aware of **incentives** behind different payment mechanisms.  
- **Source**: Acknowledgement to Cheryl Cashin for the passive-to-strategic purchasing framework.  

---

## âš–ï¸ 5. Resource Allocation and Rationing  

### ðŸ“‹ Decision-Making in Allocation  
- **Key Decisions**:  
  - **What services to provide**: Prioritizing interventions.  
  - **What to pay for**: Using **economic evaluations** to assess alternatives.  
  - **Who shall be covered**: Determining eligible populations.  
- **Challenges**:  
  - **Rationing of Care**: Deciding who receives limited resources due to scarcity.  
  - **Ethical Implications**: Balancing **equity** and **efficiency**.  
  - **Can Rationing Be Avoided?**: A critical policy question.  

---

## ðŸ“ˆ 6. Analyzing Health Expenditures  

### ðŸ” Basics of Financing: Understanding Expenditures  
- **Key Question**: *How do you know what a country spends on healthcare?*  
- **Challenges**:  
  - Comparing expenditures across **time** requires adjusting for **inflation**.  
  - Comparing across **countries** requires adjusting for **currency differences** and **purchasing power**.  

#### **Time Value of Money**  
- **Question**: *Is a dollar today worth a dollar tomorrow?*  
- **Answer**: No, due to **inflation** and the **time value of money**.  
  - A unit of currency is **worth more now** than in the future.  
  - A unit of currency is **worth less now** than in the past.  

#### **Adjusting for Inflation**  
- **Need**: Expenditures must be adjusted for **inflation** to ensure comparability over time.  
- **Tools**:  
  - **Gross Domestic Product (GDP) Deflators**: Adjusts for economy-wide price changes.  
  - **Consumer Price Index (CPI)**: Measures changes in consumer goods prices.  
- **Example**: Total Health Expenditure (THE) in Malaysia (1997â€“2021):  

| **Year**     | **THE (Current RM)** | **THE (Adjusted to 2021 RM)** |
| ------------ | -------------------- | ----------------------------- |
| 1997         | RM 8.6 billion       | RM 18.3 billion               |
| 2021         | RM 78.2 billion      | RM 78.2 billion               |
| **Increase** | 809% (current)       | 380% (adjusted)               |

- **Calculation (Base Year 2021)**:  
  - For 1997:  
    $$ \text{Constant 1997 THE} = \frac{111.4 \times 8.6}{52.1} = \text{RM 18.4 billion} $$  
  - For 2010:  
    $$ \text{Constant 2010 THE} = \frac{111.4 \times 32.9}{90.4} = \text{RM 40.5 billion} $$  
  - **GDP Deflators**: 1997 (52.1), 2010 (90.4), 2021 (111.4).  
- **Inflation Rate Example (2020â€“2024)**:  
  - Price of a burger: RM 6.00 (2020), RM 6.60 (2024).  
  - $$ \text{Inflation Rate} = \frac{6.60 - 6.00}{6.00} = 10\% $$  
- **Source**: Malaysia National Health Accounts, Health Expenditure Reports (various years).  

#### **Cross-Country Comparisons**  
- **Question**: *Can a dollar buy the same amount of goods in every country?*  
- **Challenges**:  
  - **Different currencies**.  
  - **Different purchasing power** of currencies.  
- **Adjustments**:  
  - **Official Currency Exchange Rates**: Convert to a common currency (e.g., USD).  
  - **Purchasing Power Parity (PPP) Rates**: Reflects real purchasing power.  
- **Example**: National Health Expenditures (2022, per capita):  

| **Country** | **Per Capita CHE (Currency Rate, USD)** | **Per Capita CHE (PPP Rate, USD)** | **Currency** |
| ----------- | --------------------------------------- | ---------------------------------- | ------------ |
| China       | 672 (4,530 Renminbi)                    | 1,136                              | Renminbi     |
| India       | 80 (6,250 Indian Rupee)                 | 273                                | Indian Rupee |
| Malaysia    | 458 (2,017 Ringgit)                     | 1,281                              | Ringgit      |
| Myanmar     | 58 (111,502 Myanmar Kyat)               | 242                                | Myanmar Kyat |
| Singapore   | 4,371 (5,957 SGD)                       | 6,658                              | SGD          |
| USA         | 12,434                                  | 12,434                             | USD          |

  - **Source**: WHO at http://apps.who.int/nha/database/Select/Indicators/en.  
- **PPP Example**: Price of a burger:  
  - Malaysia: RM 15.45  
  - USA: USD 5.35  
  - **Implied Exchange Rate**:  
    $$ \text{Exchange Rate (RM to USD)} = \frac{15.45}{5.35} = \text{RM 2.89 to USD 1.00} $$  
  - **Official Rate (2022)**: RM 4.42 to USD 1.00.  
  - **Undervaluation**:  
    $$ \text{Undervalued by} = \frac{2.89 - 4.42}{2.89} = -53\% $$  
  - **Conclusion**: Malaysian Ringgit is **undervalued by ~53%**.  
- **Exchange Rates (2022)**:  

| **Country** | **Currency Exchange Rate (NCU/USD)** | **PPP Exchange Rate (NCU/USD)** |
| ----------- | ------------------------------------ | ------------------------------- |
| China       | 6.74                                 | 3.99                            |
| India       | 78.60                                | 22.88                           |
| Malaysia    | 4.40                                 | 1.57                            |
| Myanmar     | 1,923.48                             | 460.86                          |
| Singapore   | 1.38                                 | 0.89                            |
| USA         | 1.00                                 | 1.00                            |

  - NCU: National Currency Unit.  

---

## ðŸ’µ 7. Modalities of Health Care Financing  

### ðŸ“‹ Overview  
Countries use a **combination of financing modalities**, differing in their **relative proportions**. The main modalities include:  
- General taxation  
- Social insurance  
- Private insurance  
- Out-of-pocket (OOP) payments  
- Others: Medical Savings Accounts, Community Health Financing  

#### **General Taxation**  
- **Definition**: *Funds collected through direct (e.g., income tax) or indirect (e.g., sales tax) taxes to finance social programs like health and education.*  
- **Categories**:  
  - **Direct Taxes**: E.g., income tax.  
  - **Indirect Taxes**: E.g., sales tax on goods and services.  
- **Advantages**:  
  - **Progressive Taxation**:  
    - **Progressive Tax System**: *Taxes rise as a proportion of income as income rises.*  
    - **Regressive Tax System**: *Taxes fall as a proportion of income as income rises.*  
    - **Proportional System**: *Taxes are the same proportion of income for all, irrespective of income.*  
    - **Example**:  
      - Mr. A: Pays RM 100 for healthcare, earns RM 1,000/month (10% of income).  
      - Mr. B: Pays RM 200 for healthcare, earns RM 4,000/month (5% of income).  
      - **Analysis**: This is **regressive**, as the lower-income individual pays a higher proportion.  
  - **Social Justice**:  
    - Acts as an **instrument** to achieve equitable wealth distribution.  
    - Supports **vulnerable groups** (e.g., poor, elderly).  
    - Funds **public goods** (non-rivalrous, non-excludable, e.g., lighthouses, health information, clean air) and **merit goods** (under-consumed by market, e.g., vaccines, vector control, screening programs).  
  - **Political Will**: Required for progressive implementation.  
- **Disadvantages**:  
  - **Revenue Variability**: Depends on:  
    - **Wealth of the country**.  
    - **Taxable base**.  
    - **Competition** with other national needs (e.g., defense).  
    - **Fluctuates** year to year.  
  - **Inadequate Funds**: May not meet healthcare demands.  
  - **Reliance on Indirect Taxes**: Often **regressive**, burdening the poor and those less able to pay.  
- **Examples**:  
  - **Hospital Authority** in Hong Kong.  
  - **Public health services** in Malaysia.  

#### **Health Insurance**  
- **Definition**: *Provides protection against the uncertainty of ill-health and associated financial costs through risk pooling.*  
- **Mechanism**:  
  - **Risk Pooling**: Spreads risk across the insured population.  
  - **Predictability**: While individual ill-health is uncertain, group-level patterns can be predicted.  
- **Categories**:  
  - **Private Health Insurance**: Market-based, voluntary, or employer-sponsored.  
  - **Social Health Insurance**: Government-backed, often mandatory with contributions from employers and employees.  

#### **Out-of-Pocket (OOP) Household Expenditures**  
- **Definition**: *Any payments made directly to healthcare providers, including user fees and payments for medicines.*  
- **Characteristics**:  
  - Coexists with other schemes (e.g., co-payments in insurance, user fees in public services).  
  - **Over-reliance** can **decrease accessibility** for the poor, undermining equity.  

#### **Medical Savings Accounts (MSAs)**  
- **Definition**: *Individual savings accounts restricted to spending on healthcare.*  
- **Context**: Exists within a countryâ€™s broader financing system.  
- **Examples**:  
  - **Singapore**: **Medisave**, a medical savings account component of the **Central Provident Fund (CPF)**.  
  - **Malaysia (pre-2007)**: **Employees Provident Fund (EPF)** savings earmarked for critical illness expenses.  
  - Others: South Africa, USA.  
- **Malaysia EPF Details**:  
  - Established under **EPF Ordinance 1951**.  
  - Compulsory savings scheme for employment benefits.  
  - Secondary role as an **alternative financing source** for healthcare.  
  - **1994 Restructuring**: Created individual savings accounts for **critical illness expenses** for members and dependents.  
  - **Abolished in 2007**: Health-specific accounts discontinued.  
- **Issue**: Uncertainty about whether individuals can **save enough** for all healthcare needs.  
- **Linkage**: Often paired with **catastrophic insurance** to cover large, unexpected expenses.  

#### **Community Health Financing**  
- **Context**: Prevalent in **rural areas** of **low-income countries** where market and public systems fail to provide access.  
- **Features**:  
  - **Mainly voluntary**.  
  - **Payment for healthcare** made by the community.  
  - **Community control** of resources and their management.  
- **Mechanisms**: Often based on **social insurance** principles.  
- **Examples**:  
  - **SEWA, Gujarat, India**: Health, life, and asset insurance for women working in the informal sector.  
  - **Grameen Bank Health Programme, Bangladesh**: Benefits for Grameen Bank members.  
  - **Bamako Initiative**: Revolving fund for essential drugs.  

#### **Health Financing in Singapore**  
- **Sources of Funds**:  

| **Source**                        | **Description**                                                  |
| --------------------------------- | ---------------------------------------------------------------- |
| **General Taxation**              | Government provides subsidies in restructured health facilities. |
| **Medisave**                      | Medical savings account component of Central Provident Fund.     |
| **MediShield**                    | Public catastrophic illness insurance.                           |
| **MediFund**                      | Endowment fund for the poor.                                     |
| **ElderShield & CareShield Life** | Disability insurance for long-term care.                         |
| **Out-of-Pocket Payments**        | Direct payments by individuals.                                  |

---

## ðŸ§­ 8. Factors Shaping Financing Systems  

### ðŸ“‹ Determinants of Financing Choices  
- **Multiple Factors**:  
  - **Political and Cultural Context**: E.g., the UKâ€™s **NHS** reflects a social philosophy of universal access.  
  - **Socioeconomic Development**:  
    - **Low-Income Countries**: Higher reliance on **private sources**, especially **OOP payments**.  
    - **High-Income Countries**: Greater use of **public sources** (e.g., taxation, social insurance).  
    - Ability to obtain funds correlates with **per capita income**.  
  - **Economic Structure**: A larger working population increases the **tax base**.  
  - **Populationâ€™s Willingness to Pay**: Trust and acceptance of pooling funds.  
  - **Organizational Capacity**: Efficient and effective **fund collection** from employees, employers, and other groups.  
  - **Role of Informal Payments**: Can undermine formal financing systems.  

---

## ðŸ“Š 9. National Health Accounts (NHAs)  

### ðŸ“– What are National Health Accounts?  
- **Definition**: *A set of descriptive accounts that describe the totality of expenditure flows in both government and non-government sectors, detailing the source, destination, and uses of funds in the health sector.*  
- **Purpose**:  
  - Answers key questions:  
    - *Who paid, who did they pay to, and what did they get for their payment?*  
    - *How are resources used, for what services, and for whom?*  
  - Provides **evidence** to help **policymakers**, **nongovernmental stakeholders**, and **managers** make better decisions to improve **health system performance**.  

### ðŸŒ System of Health Accounts  
- **Developed by**: **OECD**, used by many countries, including Malaysia.  
- **Features**:  
  - Provides **internationally comparable health accounts** through **standard tables**.  
  - Defines **internationally harmonized boundaries** of healthcare.  
- **Sources**:  
  - Organization for Economic Cooperation and Development, Eurostat, & World Health Organization (2017). *A System of Health Accounts 2011. Revised Edition*. Paris: OECD.  
  - Ministry of Health Malaysia (2006). *Malaysia National Health Accounts Project. Report on the MNHA Classification System (MNHA Framework)*. Putrajaya: MOH Malaysia.  

### ðŸ“ˆ What Constitutes Health Expenditures?  
- **Definition**: *Health spending consists of health and health-related expenditures, defined by their primary purpose, regardless of the entity providing or paying for the services.*  
- **Scope**:  
  - Includes **health of individuals** and **populations**.  
  - Covers **medical care**, **prevention**, **promotion**, **rehabilitation**, **community health activities**, **health administration**, **regulation**, and **capital formation**.  
- **Health-Related Expenditures**: Include **medical education**, **training**, and **research and development**.  
- **Malaysiaâ€™s Definition**:  
  - **Current Expenditure on Health Care**: *Final consumption expenditure of resident units on healthcare goods and services, including both individual and collective healthcare services.*  
- **OECD Definition**: Aligns with Malaysiaâ€™s framework for comparability.  
- **Source**: Ministry of Health Malaysia (2006). *Malaysia National Health Accounts Project. Report on the MNHA Classification System (MNHA Framework)*. Putrajaya: MOH Malaysia.  

### ðŸ“Š Malaysian Health Spending (2021)  
- **Total Health Expenditure (THE)**:  
  - **RM 78.2 billion**, or **5.1% of GDP**.  
  - **Per Capita THE**: RM 2,401.  
- **Current Health Expenditure (CHE)**:  
  - **RM 68.0 billion**, or **4.4% of GDP**.  
  - **Per Capita CHE**: RM 2,089.  
- **Out-of-Pocket Payments (OOPPs)**:  
  - **THE**: RM 24.6 billion, or **31.5% of THE**.  
  - **CHE**: RM 23.1 billion, or **34.1% of CHE**.  
  - **Per Capita OOPP**: RM 756 (THE), RM 711 (CHE).  
- **Sources of Health Financing (1997â€“2021)**:  
  - Mix of **public** (e.g., taxation) and **private** (e.g., OOP, insurance) sources.  
  - Trend shows increasing **THE as % of GDP**, with fluctuations in public vs. private contributions.  
- **THE by Function (2011â€“2021)**:  

| **Function**                    | **Share (2021)** | **Trend (2011â€“2021)**  |
| ------------------------------- | ---------------- | ---------------------- |
| **Curative Care Services**      | ~31.0%           | Stable, ~30%           |
| **Public Health Services**      | 13.1%            | 8.7â€“13.1%              |
| **Medical Goods (Outpatient)**  | 13.0%            | ~10â€“13%                |
| **Health Administration**       | 9.7%             | ~9â€“10%                 |
| **Rehabilitative Care**         | ~5â€“10%           | Variable               |
| **Long-term Nursing Care**      | ~1â€“2%            | Low, stable            |
| **Ancillary Services**          | ~5â€“10%           | Variable               |
| **Health-Related Expenditures** | ~10â€“15%          | Includes R&D, training |

- **OOPPs by Function (2011â€“2021)**:  

| **Function**                             | **Share (2021)** | **Trend (2011â€“2021)** |
| ---------------------------------------- | ---------------- | --------------------- |
| **Outpatient Services**                  | 6.0%             | 6.0â€“10.2%             |
| **Pharmaceuticals**                      | 6.9%             | 6.7â€“8.4%              |
| **Traditional & Complementary Medicine** | ~6.0%            | ~6â€“8%                 |
| **Inpatient Services**                   | ~5â€“10%           | Variable              |
| **Medical Appliances & Non-durables**    | ~1â€“2%            | Low, stable           |
| **Health Education & Training**          | ~1â€“2%            | Low, stable           |
| **Daycare Services**                     | ~1â€“2%            | Low, stable           |
| **All Other Functions**                  | ~6.0%            | ~6â€“10%                |

- **Sources**:  
  - Ministry of Health Malaysia (2021). *Malaysia National Health Accounts. Health Expenditure Report (1997â€“2019)*. Putrajaya: MOH Malaysia.  
  - Ministry of Health Malaysia (2023). *Malaysia National Health Accounts. Health Expenditure Report (2011â€“2021)*. Putrajaya: MOH Malaysia.  

---

## âœ… 10. Summary: Key Takeaways  

| **Area**                     | **Key Insight**                                                                 |
|------------------------------|---------------------------------------------------------------------------------|
| **Health Financing Goals**   | Achieve **risk protection**, **equity**, and **access** through effective systems. |
| **Mechanisms**               | **Revenue collection**, **fund pooling**, and **purchasing** are core components. |
| **Modalities**               | Include **taxation**, **insurance**, **OOP payments**, **MSAs**, and **community financing**. |
| **Comparisons**              | Adjust expenditures using **PPP** and **inflation** for accurate time and country comparisons. |
| **National Health Accounts** | Crucial for **policy**, **planning**, and ensuring **transparency** in health spending. |

---

# HE 5 - Health Insurance and Managed Care  

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Prof. Dr. Ng Chiu Wan**  
**Dept. of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  
**Lecture Date: 17th April 2025**  

---

## ðŸ“š 1. Introduction and Recap on Health Financing  

**Health insurance** and **managed care** are critical mechanisms for financing healthcare, addressing **cost control**, **equity**, and **access** to services. This lecture builds on health financing principles, exploring **insurance systems**, **managed care strategies**, and their role in achieving **universal health coverage (UHC)**.

### ðŸ” Recap on Health Financing  
- **Functions of Health Financing**:  
  - **Revenue Collection**: Mobilizing funds from households, organizations, and donors.  
  - **Fund Pooling**: Accumulating and managing revenue to share financial risks.  
  - **Purchasing of Services**: Allocating funds to providers for healthcare delivery.  
- **Main Financing Modalities**:  
  - **General Taxation**: Public funding through direct (e.g., income tax) or indirect (e.g., sales tax) taxes.  
  - **Health Insurance**: Includes social and private insurance schemes.  
  - **Out-of-Pocket (OOP) Payments**: Direct payments by individuals to providers.  
- **Impact on Distribution**:  
  - Each modality affects **who bears the cost** of healthcare, influencing **equity** and **access**.  
- **National Health Accounts (NHAs)**:  
  - *A set of descriptive accounts tracking the totality of expenditure flows in government and non-government sectors.*  
  - Answers: *Who paid, who did they pay to, and what did they get for their payment? How are resources used, for what services, and for whom?*  
  - Provides **evidence** for policymakers, stakeholders, and managers to improve **health system performance**.  

### â“ Why Distribution Matters  
- **Equity Implications**: The distribution of health expenditures determines whether costs disproportionately burden the **poor** or **rich**, affecting **access** and **financial protection**.  
- **Key Question**: *Does the distribution of health expenditures exacerbate inequalities?*

---

## âš–ï¸ 2. Equity in Health Expenditures  

### ðŸ“ˆ Out-of-Pocket (OOP) Concentration Curve  
- **Definition**: *Plots the cumulative proportion of OOP health payments against the cumulative proportion of the population ranked by socioeconomic status (SES).*  
- **Purpose**: Visualizes **inequality** in the burden of OOP payments across income groups.  
- **Graphical Representation**:  
  - **X-Axis**: Cumulative proportion of population, from **poorest** to **richest**.  
  - **Y-Axis**: Cumulative proportion of **OOP payments**.  
  - **Diagonal (Line of Equality)**: Represents perfect equity, where OOP payments are proportional to population share.  
- **Examples**:  
  - **Above Diagonal**: Poorest 50% of the population account for **75% of total OOP payments**, indicating **inequality where the poor bear a greater share**.  
  - **Below Diagonal**: Poorest 50% account for **25% of total OOP payments**, indicating **inequality where the rich bear a greater share**.  
- **Interpretation**:  
  - **Further from Diagonal**: Greater **inequality**.  
  - **Above Diagonal**: **Poor** bear a **disproportionately higher burden** (regressive).  
  - **Below Diagonal**: **Rich** bear a **disproportionately higher burden** (progressive).  
  - **On Diagonal**: **Perfect equity**.  
- **Table: OOP Concentration Curve Interpretation**  

| **Curve Position** | **Implication**                         |
| ------------------ | --------------------------------------- |
| Above Diagonal     | Poor bear more OOP burden (regressive)  |
| Below Diagonal     | Rich bear more OOP burden (progressive) |
| On Diagonal        | Perfect equity                          |

### ðŸ“Š Concentration Index (CI)  
- **Definition**: *A measurement technique that summarizes inequality in one figure, based on the concentration curve.*  
- **Calculation**: *Twice the area between the concentration curve and the line of equality.*  
  - **Formula**:  
    $$ \text{CI} = 2 \times \text{Area between curve and diagonal} $$  
- **Value Range**: From **-1** to **+1**.  
  - **CI < 0**: Inequality concentrated among the **poor** (closer to -1 indicates greater burden on the poor).  
  - **CI > 0**: Inequality concentrated among the **rich**.  
  - **CI = 0**: No correlation between OOP payments and **SES**, indicating **equity**.  
- **Source**: Khazanah Research Institute (2020). *Social Inequalities and Health in Malaysia. The State of Households 2020. Part III.*  

### ðŸš¨ Catastrophic Health Payments  
- **Definition**: *OOP spending that exceeds a critical percentage of household resources, likely forcing cuts in essential consumption, asset sales, debt, or impoverishment.*  
- **Typical Thresholds**:  
  - **>10% of total household consumption**.  
  - **>40% of household capacity to pay** (income after essential expenses).  
- **Source**:  
  - Van Doorslaer, E., et al. (2007). *Catastrophic payments for health care in Asia.* *Health Economics*, 16, 1159â€“84.  
  - Wagstaff, A., et al. (2018). *Progress on catastrophic health spending in 133 countries.* *Lancet Global Health*, 6, e169â€“e179.  
- **Lack of Consensus**: Diverse thresholds indicate no universal agreement on defining catastrophic payments.  

### ðŸ“‰ Poverty Impact of OOP Payments  
- **Purpose**: Examines whether OOP payments **push households into poverty** or deepen existing poverty.  
- **Indices**:  
  - **Poverty Headcount**: Proportion of individuals/households below the poverty line.  
  - **Poverty Due to OOP**: Difference in headcounts before and after deducting OOP payments from income.  
- **Global Poverty Lines**:  
  - **$2.15/day** (2017 PPP-adjusted).  
  - **Country-Specific**: E.g., 60% of median per capita consumption/income.  
- **Consequences**:  
  - **Impoverishment**: Pushes households below the poverty line.  
  - **Deterred Care-Seeking**: Financial barriers reduce access to needed services.  
  - **Negative Welfare Impact**: Deprives resources for essentials (e.g., food, education), especially for **poor families**.  
- **Sources**:  
  - Van Doorslaer, E., et al. (2006). *Effect of payments for health care on poverty estimates in 11 countries in Asia.* *Lancet*, 368, 1357â€“64.  
  - Wagstaff, A., et al. (2018). *Progress on impoverishing health spending in 122 countries.* *Lancet Global Health*, 6, e180â€“e192.  

### ðŸ“Š OOP Payments as % of Current Health Expenditure (CHE)  
- **Data**: Trends from 2000â€“2021 across income groups.  
- **Figure**:  
  - **High-Income Countries**: OOP payments decreased (e.g., ~15% of CHE in 2021).  
  - **Upper-Middle-Income**: ~30% of CHE.  
  - **Lower-Middle-Income**: ~38% of CHE.  
  - **Low-Income**: ~50% of CHE.  
- **Source**: World Health Organization Global Health Observatory Database, accessed 21st October 2024.  
- **Implication**: Higher OOP reliance in **low-income countries** increases **financial hardship** risks.  

---

## ðŸ—‚ï¸ 3. Lecture Contents  

The lecture covers:  
- **Concept of Health Insurance**: Mechanics and role in financial protection.  
- **Social Health Insurance (SHI) vs. Private Health Insurance (PHI)**: Differences in objectives, operations, and outcomes.  
- **Managed Care Techniques**: Strategies to control costs and improve delivery.  
- **Ethical and Quality Issues**: Challenges in balancing cost and care quality.  
- **Financing for Universal Health Coverage (UHC)**: Pathways to equitable access.  

---

## ðŸ©º 4. Concept of Health Insurance  

### ðŸ“– What is Insurance?  
- **Definition**: *A prepayment into a common fund that pays providers for future healthcare needs, protecting patients against financial loss.*  
- **Functions**:  
  - **Risk Pooling**: Spreads financial risk across the insured population.  
  - **Financial Protection**: Shields against high costs of ill-health.  
  - **Access Enhancement**: Reduces barriers to care.  

### ðŸ›¡ï¸ Health Insurance  
- **Purpose**: *Provides protection against the uncertainty of ill-health and associated financial costs.*  
- **Key Features**:  
  - **Individual Uncertainty**: Ill-health in individuals is unpredictable.  
  - **Group Predictability**: Ill-health patterns in groups can be estimated.  
  - **Risk Pooling**: Distributes costs across the **insured population**.  
- **Target Audience**: Appeals to **risk-averse individuals** who prefer predictable costs (premiums) over potential catastrophic expenses.  

### ðŸ˜Ÿ Risk-Averse Individuals  
- **Who Buys Insurance?**:  
  - *A person who canâ€™t accept the risk of financial losses in the event of illness.*  
- **With Insurance**:  
  - **Definite Loss**: Premium payments.  
  - **No Additional Risk**: No further financial loss if illness occurs.  
- **Without Insurance**:  
  - **No Initial Loss**: No premium payments.  
  - **High Risk**: Potential for large losses if illness occurs.  
- **Contrast**: **Risk-loving individuals** may avoid insurance, accepting the gamble of no coverage.  

---

## ðŸ”„ 5. Social Health Insurance (SHI) vs. Private Health Insurance (PHI)  

### ðŸ“‹ Overview  
- **Two Categories**:  
  - **Social Health Insurance (SHI)**: Government-mandated, aims for universal coverage.  
  - **Private Health Insurance (PHI)**: Voluntary, market-based, profit-driven.  
- **Fundamental Objectives**:  
  - **SHI**: *Eventual aim to provide universal health coverage.*  
  - **PHI**: *Mainly to meet individualâ€™s needs.*  

### ðŸ†š Comparison of SHI and PHI  
| **Aspect**                  | **SHI**                                                                          | **PHI**                                                    |
| --------------------------- | -------------------------------------------------------------------------------- | ---------------------------------------------------------- |
| **Objective**               | Universal health coverage                                                        | Meet individual needs                                      |
| **Enrollment**              | Mandated by government, aims for universal coverage                              | Voluntary, market-driven                                   |
| **Premium Setting**         | Community-rated (same for all)                                                   | Individually risk-rated (varies by risk)                   |
| **Premium Payment**         | Salary-based deductions (employer/employee), government subsidies for vulnerable | Paid by individuals or employers, from savings or benefits |
| **Fund Pooling**            | Large pools, state-managed, single or few funds                                  | Smaller pools, insurer-managed                             |
| **Benefit Package**         | Comprehensive, regulated for community health needs                              | Flexible, tailored to market demands                       |
| **Administrative Capacity** | High; requires premium collection, strategic purchasing, provider contracts      | Lower scale, profit-focused administration                 |

#### **Enrollment**  
- **SHI**:  
  - *Policyholders are encouraged or obliged to insure through third-party intervention, usually mandated by the government.*  
  - **Features**:  
    - **Broad Coverage**: Gradually extends from **formal sector** to **self-employed** and **informal sector**, aiming for **universal coverage**.  
    - **Reduces Adverse Selection**: Mandatory participation ensures a mix of healthy and high-risk individuals.  
  - **Roll-Out**: Starts with formally employed, expands to universal coverage.  
- **PHI**:  
  - **Voluntary**: Individuals or employers choose to enroll based on personal needs or benefits packages.  

#### **Adverse Selection**  
- **Definition**: *Persons with pre-existing conditions or higher illness risks are more likely to join insurance plans, while healthy individuals have less incentive.*  
- **Impact**:  
  - Creates a fund with **more ill/old than healthy/young members**.  
  - Increases **average risk**, leading to **higher premiums**.  
  - Drives **healthy individuals** out due to unaffordable premiums.  
- **PHI Strategy**:  
  - Uses **risk-based premiums** (higher for high-risk individuals).  
  - **Cherry Picking**: Sets conditions to attract **young and healthy** clients to maximize profits.  

#### **Premium Setting**  
- **SHI**:  
  - **Community-Rated**: *Premiums based on the average risk of ill-health in the entire community, not individual risk.*  
  - **Example**: Same rates for **young/old**, **sick/healthy**.  
  - **Motivation**: Equity and universal coverage, not profit.  
- **PHI**:  
  - **Individually Risk-Rated**: *Premiums reflect the individualâ€™s risk of falling ill.*  
  - **Example**: Higher premiums for **males**, **older individuals**, or those with **pre-existing conditions**.  
  - **Cherry Picking**: Encourages **low-risk** individuals to join, maximizing insurer profits.  

#### **Premium Payment**  
- **SHI**:  
  - **Contributions**: From **employer** and **employee** via **salary deductions** (wage-based for formal sector).  
  - **Informal Sector**: Various mechanisms (e.g., flat rates).  
  - **Government Assistance**: Subsidies for those unable to pay (e.g., **poor**, **elderly**, **unemployed**).  
- **PHI**:  
  - **Direct Payments**: By **individuals** (annually, from savings) or **employers** (as part of remuneration).  
  - **Employer Role**: May **self-insure** or purchase PHI for employees.  

#### **Fund Pooling**  
- **SHI**:  
  - *Pooling of risk through single or multiple funds, usually managed by quasi-government bodies.*  
  - **Advantages of Single/Few Funds**:  
    - **Greater risk pooling**.  
    - **Economies of scale**.  
  - **Role**: Funds act as **purchasers of care**.  
- **PHI**:  
  - *Generally smaller extent of pooling compared to SHI.*  
  - Focuses on **individual or group-level** risk management.  

#### **Benefit Packages**  
- **SHI**:  
  - *Designed to be comprehensive, regulated, and stipulated in a benefit package.*  
  - **Objective**: Meet **community health needs** rather than individual demands.  
  - **Content Selection**:  
    - Crucial for **long-term sustainability** of funds.  
    - Balances **cost-effective services** with **community requests**.  
    - Requires **agreement** between government and community.  
  - **Limitation**: May be constrained by **available funds**, as limited resources cannot cover all services.  
- **PHI**:  
  - *Flexible packages sensitive to market demands.*  
  - Tailored to **consumer preferences**, often excluding high-cost conditions to maintain profitability.  

#### **Administrative Capacity**  
- **SHI Requirements**:  
  - **Premium Collection**: Robust systems for contributions.  
  - **Investment Strategies**: Managing pooled funds.  
  - **Strategic Purchasing**: Contracting with providers for efficient service delivery.  
  - **Purchaser-Provider Split**: Separating funding and service provision.  
  - **Identification of Insured**: Tracking eligible members.  
  - **Reimbursement of Providers**: Timely payments.  
- **PHI**: Similar but on a **smaller scale**, with a focus on **profit-driven operations**.  

#### **SHI Evolution**  
- **Traditional**:  
  - *Participation mainly by formal sector workers.*  
  - **Mandated by law**.  
  - **Contributions**: Fixed percentage of wages from workers and employers.  
  - **Coverage**: Limited to contributors.  
- **Modern**:  
  - *Coverage of all citizens, including those who contribute and those who do not.*  
  - **Mandatory Contributions**: From formal sector workers and employers.  
  - **General Tax Revenues**: Used to cover the rest (e.g., **poor**, **unemployed**, **informal sector**).  

#### **SHI: Advantages**  
- **Mobilizes Additional Resources**: Funds healthcare through contributions.  
- **Expands Coverage**: Reaches more people, including informal sectors.  
- **Private Sector Choice**: Allows insured to access **private providers**, reducing **public sector pressure**.  
- **Increases Efficiency**: Competition between public and private providers may improve **service delivery**.  
- **Social Solidarity**:  
  - **Rich cross-subsidize the poor**.  
  - **Healthy cross-subsidize the sick**.  
  - **Government support** for those unable to pay.  
- **Net Effect**:  
  - **Reduces financial barriers** to healthcare.  
  - **Increases access** to care.  

#### **SHI: Disadvantages**  
- **Pay-as-You-Go System**:  
  - *Current revenue funds current expenditures.*  
  - **Challenge**: **Ageing populations** reduce revenue while increasing health expenditures.  
  - **Impact**: Higher expenditures with reduced revenue lead to **expenditure deficits**.  
- **Government Intervention**: May need to use **tax funds** to cover shortfalls.  

#### **PHI: Advantages**  
- **Highly Responsive to Individual Needs**:  
  - Sensitive to **market forces** and **consumer demand**.  
  - Offers tailored coverage based on preferences.  

#### **PHI: Disadvantages**  
- **Equity Issues**:  
  - *Purchase of coverage limited to those who can afford.*  
  - Excludes high-risk or low-income individuals, exacerbating **inequities**.  

---

## âš ï¸ 6. Moral Hazard in Health Insurance  

### ðŸ“– What is Moral Hazard?  
- **Definition**: *Occurs when an individual insulated from risk behaves differently than they would if fully exposed to the risk.*  
- **In Health Insurance**:  
  - *Existence of insurance cover changes the behavior of the insured because they no longer bear the full financial risk when consuming healthcare services.*  
  - **Effect**: Increases use of healthcare services, raising **costs** and threatening **fund sustainability**.  

### ðŸ› ï¸ Mechanisms to Manage Moral Hazard  
- **Problem**: *Moral hazard can lead to higher insurance payouts.*  
- **Solution**: Ensure care is **not free** at the point of use, balanced with **affordability** and **access** to needed care.  
- **Strategies**:  
  - **Copayments**: Fixed amounts paid per service.  
  - **Coinsurance**: Percentage of costs shared by the insured (e.g., 20%).  
  - **Deductibles**: Fixed amounts paid annually before insurer coverage begins.  

### ðŸ“‹ Health Insurance Terminology  
| **Term**         | **Definition**                                                                        |
| ---------------- | ------------------------------------------------------------------------------------- |
| **Premium**      | Amount paid for specified coverage.                                                   |
| **Coverage**     | Specified benefits that can be obtained.                                              |
| **Cost-Sharing** | Sharing of costs between insured and insurer.                                         |
| **Deductible**   | Fixed amount paid by insured over a period (e.g., a year) before insurer cost-shares. |
| **Coinsurance**  | Percentage of costs shared by insured (e.g., 20%).                                    |
| **Copayments**   | Fixed amount paid each time before insured receives care.                             |

---

## ðŸ’¬ 7. SHI vs. Tax-Based Funding Debate  

### ðŸ“– Current Debate  
- **Choice of Financing**: **Social Health Insurance (SHI)** vs. **general taxation** for healthcare funding.  
- **No Automatic Superiority**: Effectiveness depends on:  
  - **Funding Structure**: How funds are collected and allocated.  
  - **Service Delivery**: Efficiency and quality of healthcare provision.  
  - **Community Served**: Socioeconomic and health needs of the population.  

---

## ðŸ§  8. Managed Care: Concepts and Evolution  

### ðŸ“– What is Managed Care?  
- **Definition**: *A set of techniques employed by third-party payers to control healthcare costs through control on use of healthcare services.*  
- **Reasons for Emergence**:  
  - **Inability of Insurers to Contain Costs**: Due to **moral hazard** and **perverse incentives** in provider payment mechanisms.  
  - **Escalating Healthcare Costs**: In the U.S., **Current Health Expenditure (CHE)** as a percentage of **GDP** increased from **12.5% in 2000 to 16.7% in 2022**.  

### ðŸ§° Managed Care Techniques  
- **Demand-Side Controls**:  
  - **Limit Patient Choice**: Restrict provider networks.  
  - **Primary Care Gatekeeping**: Emphasize primary care to reduce specialist referrals.  
  - **Encourage Prevention**: Promote cost-effective preventive services.  
- **Supply-Side Controls**:  
  - **Control Selection of Providers**: Restrict number and choice of providers.  
  - **Financial Risk-Sharing**: E.g., **fund holding by GPs**, **capitation**.  
  - **Peer Review and Quality Assurance**: Control unnecessary service use.  
- **Aim**: **Control costs and utilization** while maintaining care quality.  
- **Table: Managed Care Techniques**  

| **Demand-Side Controls** | **Supply-Side Controls**                  |
| ------------------------ | ----------------------------------------- |
| Limit patient choice     | Control selection of providers            |
| Primary care gatekeeping | Financial risk-sharing (e.g., capitation) |
| Encourage prevention     | Peer review and quality assurance         |

### âš–ï¸ Bearing Risks in Managed Care  
- **Purpose**: **Contain costs** by sharing **financial risks** with providers.  
- **Mechanism**:  
  - Incentives to change **provider behavior** (e.g., reduce unnecessary procedures).  
  - Most American **Managed Care Organizations (MCOs)** mandate **risk-sharing** with providers.  

### â“ Ethical and Quality Concerns  
- **Conflicting Aims**:  
  - *Controlling utilization of care and improvement of quality.*  
- **Main Issue**: Risk of **minimizing care** to **maximize profits**.  
- **Neutral Techniques**:  
  - Tools like **primary care gatekeeping** or **provider risk-sharing** are not inherently problematic.  
  - *Fault lies in balancing the extent of use.*  

### ðŸ¥ Types of Managed Care Organizations  
#### **Health Maintenance Organizations (HMOs)**  
- **Definition**: *A managed healthcare plan that provides or arranges comprehensive, coordinated medical services to voluntarily enrolled members on a prepaid basis.*  
- **Features**:  
  - Combines roles of **insurers** and **healthcare providers**.  
  - Delivers **comprehensive services**.  
  - **Voluntary enrollment**.  
  - **Fixed prepaid basis**.  

#### **Preferred Provider Organizations (PPOs)**  
- **Definition**: *Loose arrangements between doctors and third-party payers.*  
- **Features**:  
  - Includes **discounted fee schedules**.  
  - **Restricts provider choices**.  
  - Similar to **panel doctors** in Malaysia.  

### ðŸ‡ºðŸ‡¸ Development in America  
- **Main Driver**: **Escalating healthcare costs** and failure of traditional insurance to contain them.  
- **Context**: U.S. healthcare costs rose significantly, necessitating cost-control measures.  

### ðŸ‡²ðŸ‡¾ Managed Care in Malaysia  
- **Development**: Evolved through **three generations** since the early 1980s:  

| **Generation** | **Model**                  |
| -------------- | -------------------------- |
| 1st Generation | Panel Doctor System        |
| 2nd Generation | Third-Party Administrators |
| 3rd Generation | Medical Card Companies     |

- **Key Differences from U.S.**:  
  - **Not Cost-Driven**: *Not mainly driven by need to contain costs unlike in America.*  
  - **Administrative Convenience**: *Administrative ease for employers to administer employee health benefits.*  
  - **Not Risk Bearers**: *Malaysian MCOs are not financial risk bearers.*  
  - **Consumer Demand**: *Currently, MCOs cater to consumer demands for screening programs, which may even drive up costs.*  

---

## ðŸŒ 9. Universal Health Coverage (UHC)  

### ðŸ“– What is UHC?  
- **Definition**: *Ensuring that all people can use the promotive, preventive, curative, rehabilitative, and palliative health services they need, of sufficient quality to be effective, while ensuring that the use of these services does not expose the user to financial hardship.*  
  - **Source**: World Health Organization (2010). *World Health Report 2010. Financing for universal coverage.*  
- **Features**:  
  - **Whole Population Access**: Services available regardless of **income**, **social status**, or **residency**.  
  - **100% Coverage**: Same **scope of benefits** for all.  
- **Policy Objectives**:  
  - **Equity in Payment**: Fair contribution across income groups.  
  - **Financial Protection**: No financial hardship from healthcare costs.  
  - **Equity in Access and Utilization**: Services based on need, not ability to pay.  

### ðŸ’¸ Financing for UHC  
- **Path to Universal Access**:  
  1. **Raising Sufficient Resources**: Mobilizing funds for health through taxation, insurance, or other means.  
  2. **Removing Financial Risks and Barriers**: Ensuring affordable access via risk pooling and prepayment.  
  3. **Promoting Efficiency and Reducing Waste**: Optimizing resource use to maximize health outcomes.  
  - [Note: Fourth step incomplete, likely includes policy alignment or governance].  
- **Source**: World Health Organization (2010). *World Health Report 2010.*  

### ðŸ›¡ï¸ Financial Protection for Health  
- **Goal**: *Protecting individuals and families from excessive OOP payments.*  
- **Issues with High OOP Payments**:  
  - **Involuntary**: Often in response to unwanted health shocks.  
  - **Negative Welfare Impact**: Deprives resources for other goods and services, especially for **poor families**.  
  - **Deters Needed Services**: Financial barriers reduce access.  
- **Approaches to Assess OOP Impact**:  
  - **Catastrophic Health Payments**: Measures large expenses relative to household resources.  
  - **Poverty Impact**: Evaluates if OOP pushes households into poverty.  

### ðŸ“Š Global Trends in OOP Payments  
- **OOP as % of CHE (2000â€“2021)**:  
  - **High-Income Countries**: Declined to ~15% by 2021.  
  - **Upper-Middle-Income**: ~30%.  
  - **Lower-Middle-Income**: ~38%.  
  - **Low-Income**: ~50%.  
- **Implication**: Higher OOP reliance in **low-income countries** increases risks of **financial hardship**, **catastrophic payments**, and **impoverishment**.  
- **Source**: WHO & World Bank (2023). *Tracking Universal Health Coverage: 2023 Global Monitoring Report.*  

---

## âœ… 10. Key Takeaways  

### ðŸ“ Parting Words  
- **Risk Pooling**: *Essential for equity and providing financial risk protection.*  
- **Effective Modalities**:  
  - *Only general tax revenues and modern social health insurance can provide risk protection for entire populations.*  
- **OOP Risks**:  
  - *Population will face high risk of financial hardship if a country is heavily reliant on out-of-pocket payments (OOPPs).*  
  - Leads to **inequity**, **catastrophic payments**, and **impoverishment**.  
- **Managed Care**:  
  - *Aims to reduce costs but needs ethical balance to maintain quality.*  
- **No One-Size-Fits-All**:  
  - Health financing systems must suit the **national context**, considering governance, population needs, and administrative capacity.  
- **Balance of Modalities**:  
  - *Most countries do not rely on a single financing modality.*  
  - *The balance of all modalities affects progress towards UHC.*  

### ðŸ“Š Summary Table: Key Insights  
| **Insight**                  | **Summary**                                   |
| ---------------------------- | --------------------------------------------- |
| **Risk Pooling**             | Central to equity and financial protection    |
| **SHI & Tax Systems**        | Only modalities protecting entire populations |
| **OOP Payments**             | Risk of inequity, catastrophe, impoverishment |
| **Managed Care**             | Reduces costs but needs ethical balance       |
| **Context-Specific Systems** | Must suit national governance and needs       |

---

# HE 6 - Equality, Equity, and Social Justice  
**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Prof Ng Chiu Wan**  
**Dept. of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**  
**Date: 24th April 2025**

---

## ðŸ§­ 1. Overview and Structure  

**Equality**, **equity**, and **social justice** are foundational to addressing disparities in health and healthcare access. This lecture examines the **existence**, **magnitude**, and **fairness** of health inequalities, both **between** and **within** countries, and explores ethical frameworks and social determinants to achieve equitable health outcomes.

### ðŸ“‹ Lecture Contents  
- **Existence of Inequality in Health**: Observed differences in health outcomes.  
- **Understanding Equity in Health**: Addressing unjust and avoidable disparities.  
- **Theories of Social Justice**: Ethical frameworks guiding health policy.  
- **Determinants of Individual and Population Health**: Factors shaping health at individual and societal levels.  

### ðŸŽ¯ Questions to Ponder  
- **Do inequalities in health exist?**  
- **Do they exist between countries and within countries?**  
- **How large are these inequalities in health between and within countries?**  

---

## ðŸŒ 2. Inequality in Health  

### ðŸŒ Differences Between Countries  
- **Context**: Health outcomes vary significantly across nations due to differences in **economic development**, **healthcare systems**, and **social determinants**.  
- **Source**: Deaton, A. (2003). *Health, Inequality, and Economic Development*. *Journal of Economic Literature*, 41, 113â€“158.  
- **Example**:  
  - **Malaysia**:  
    - **GDP per capita (PPP)**: $9,421.  
    - **Life expectancy at birth**: 72 years.  
  - **Preston Curve**: Illustrates a **positive relationship** between **GDP per capita** and **life expectancy**, showing wealthier nations generally have better health outcomes.  

### ðŸ˜ï¸ Differences Within Countries  
- **Context**: Disparities within populations are driven by **socioeconomic status**, **geographic location**, **gender**, **ethnicity**, and **access to services**.  
- **Sources**:  
  - Wilkinson, R., & Marmot, M. (2003). *Social Determinants of Health: The Solid Facts*. 2nd ed. Copenhagen: WHO Regional Office for Europe.  
  - Balarajan, Y., Selvaraj, S., & Subramanian, S.V. (2011). *Health care and equity in India*. *The Lancet*, 377, 505â€“515.  
  - Khazanah Research Institute. (2020). *Social Inequalities and Health in Malaysia*. *The State of Households 2020, Part III*. Kuala Lumpur.  
  - Ministry of Health Malaysia & Harvard T.H. Chan School of Public Health. (2016). *Malaysian Health Systems Research Volume 1*.  
  - Mariapun, J., Hairi, N.N., & Ng, C.W. (2016). *Are the Poor Dying Younger in Malaysia? An Examination of the Socioeconomic Gradient in Mortality*. *PLoS ONE*, 11, e0158685.  
- **Examples**:  
  - **Gender**: Age-specific **death rates** differ between males and females (e.g., higher male mortality in certain age groups).  
  - **Ethnicity (Malaysia)**: **Indian women** showed the **largest increase in life expectancy**, indicating ethnic-specific health trends.  
    - **Data**: Preliminary analysis by Ng, C.W., Mariapun, J., & Hairi, N.N. (2010 age-specific death rates).  
  - **Geography**: **Higher infant mortality rates (IMRs)** in **rural areas** compared to urban areas in Malaysia.  
  - **Income**: **Poor households** have **lower immunization rates** and **higher tuberculosis (TB) prevalence** in India.  
- **Key Insight**: *Mortality and disease burden disproportionately affect lower socioeconomic groups.*  

### ðŸ“‰ Quantifying Inequalities  
#### **Global Poor-Rich Infant Mortality Gap**  
- **Data**: Based on 45 developing countries (average IMR = 78) compared to industrialized countries (average IMR = 7).  
- **Source**: Slides developed by Abdo Yazbeck (World Bank).  
- **Table: Global Poor-Rich Infant Mortality Gap**  

| **Indicator**                                                                              | **Value**    |
| ------------------------------------------------------------------------------------------ | ------------ |
| Actual annual infant deaths in 45 developing countries (Average IMR = 78)                  | 5.39 million |
| Estimated infant deaths in same countries at industrialized country rate (Average IMR = 7) | 0.48 million |
| Overall global poor-rich mortality gap (Actual - Estimated)                                | 4.91 million |

#### **Intra-Country Poor-Rich Infant Mortality Gap**  
- **Data**: Compares infant mortality across wealth deciles within the same 45 developing countries.  
- **Table: Intra-Country Poor-Rich Infant Mortality Gap**  

| **Indicator**                                                             | **Value**    |
| ------------------------------------------------------------------------- | ------------ |
| Actual annual infant deaths in 45 developing countries (Average IMR = 78) | 5.39 million |
| Estimated infant deaths at top wealth decile rate (Average IMR = 33)      | 2.28 million |
| Annual infant deaths prevented by eliminating intra-country poor-rich gap | 3.11 million |

#### **Contribution of Intra-Country Differences**  
- **Calculation**:  
  $$ \text{Percentage of global gap} = \frac{\text{Intra-country gap}}{\text{Global gap}} \times 100 = \frac{3.11}{4.91} \times 100 = 63\% $$  
- **Table: Contribution to Poor-Rich Infant Mortality Gap**  

| **Indicator**                                                             | **Value**    |
| ------------------------------------------------------------------------- | ------------ |
| Overall global poor-rich mortality gap                                    | 4.91 million |
| Annual infant deaths prevented by eliminating intra-country gap           | 3.11 million |
| Percentage of global gap removed by eliminating intra-country differences | 63%          |

- **Key Insight**: *Eliminating intra-country inequalities would reduce 63% of the global excess infant deaths, highlighting the critical role of within-country disparities.*  

### ðŸ“Š Specific Examples of Health Inequalities  
- **Age and Disease**:  
  - People aged **60 and above** have a **higher prevalence of coronary heart disease** than those aged 20.  
- **Socioeconomic Status**:  
  - In Thailand, the **poorest 20% of households** have **nearly double the under-5 mortality rate** compared to the richest 20%.  
- **Gender**:  
  - **Elderly women** have a **higher incidence of osteoporosis** than elderly men.  
  - **Men** do not suffer from **cervical cancer**, and **women** do not suffer from **prostate cancer**.  
- **Geographic Location**:  
  - In Laos, **urban mothers** have **5 times higher coverage of skilled birth attendance** than rural mothers.  
  - In Malaysia, **acute diarrhea** has a **higher incidence and severity** in **rural areas** compared to urban areas.  
  - In Malaysia, **infant mortality rates** are **higher in rural areas** than in urban areas.  
- **Poverty and Disease**:  
  - In India, **TB prevalence** is significantly higher among those **below the poverty line** compared to those above.  
- **Childhood Immunization**:  
  - In rural India, children from **poorer households** are **less likely to be fully immunized** and **more likely to have no immunizations** compared to those from the richest households.  

### â“ Are These Differences Acceptable or Fair?  
- **Table: Opinions on Health Inequalities**  

| **Situation**                                         | **Opinion**                          |
| ----------------------------------------------------- | ------------------------------------ |
| Higher coronary heart disease in 60+ vs. 20s          | Acceptable (age-related, biological) |
| Poorest 20% in Thailand have double under-5 mortality | Unfair (avoidable, socioeconomic)    |
| Higher osteoporosis in elderly women than men         | Acceptable (biological)              |
| Higher TB prevalence among poor in India              | Unfair (avoidable, socioeconomic)    |
| Men do not suffer from cervical cancer                | Acceptable (biological)              |
| Women do not suffer from prostate cancer              | Acceptable (biological)              |
| Higher infant mortality in rural Malaysia             | Unfair (avoidable, geographic)       |

---

## âš–ï¸ 3. Equity in Health  

### â“ Main Question  
- *When is an inequality in health an inequity?*  

### ðŸ§¾ Definitions  
- **Inequality**: *Observed differences in health outcomes or access to healthcare across groups.*  
- **Inequity**: *Differences in health which are unnecessary, avoidable, unjust, and unfair.*  
  - **Source**: Whitehead, M. (1991). *The concepts and principles of equity and health*.  
- **Key Criterion**: Inequities arise when differences are **avoidable** and stem from **lack of control** over health-promoting or health-damaging conditions.  
- **No Universal Consensus**: Determining what is **unjust** or **unfair** depends on societal values and context.  
- **Examples**:  
  - **Acceptable Inequality**: Men do not suffer from **cervical cancer**, but women do (biological).  
  - **Inequity**: Children from poor households have **less vaccination coverage** than those from richer households (avoidable, unjust).  

### âœ… Generally Fair Differences  
- Due to **biological variation** (e.g., gender-specific diseases like cervical or prostate cancer).  
- Due to **freely chosen health-damaging behavior** (e.g., smoking).  
- Due to **freely chosen health-promoting behavior** (e.g., regular exercise).  

### âŒ Generally Unfair Differences  
- Due to **health-damaging behavior** where **choice is limited** (e.g., exposure to poverty, poor living conditions).  
- Due to **exposures to unhealthy and stressful working and living conditions**.  
- Due to **inadequate access** to basic health and social services.  
- Due to **health-related social mobility** (e.g., illness leading to loss of income or status).  

### ðŸ”— Link to Health Services  
- **Key Insight**: *Inequities in health outcomes are often related to inequalities in the use of health services.*  
- **Example**: Lower access to **skilled birth attendance** in rural areas contributes to higher maternal and infant mortality.  

### âš–ï¸ Inverse Care Law  
- **Definition**: *â€œThe availability of good medical care tends to vary inversely with the need for it in the population served.â€*  
  - **Source**: Hart, J.T. (1971). *The Lancet*, 27 February 1971.  
- **Observation**:  
  - **Higher-income groups** make **better use** of health services, receiving **more specialist attention**, occupying **better-equipped and staffed hospitals**, receiving **more elective surgery**, having **better maternal care**, and being **more likely to get psychiatric help and psychotherapy** than low-income groups, particularly the unskilled.  
  - **Lower-income groups**, despite greater health needs, receive **less care**.  
- **Implication**: This exacerbates **inequities**, as those with the **greatest need** face **barriers to access**.  

### ðŸ§¬ Case Study: Breast Cancer Incidence in the U.S. (1992â€“2005)  
- **Source**: Yazbeck, A.S. (2009). *Attacking inequality in the health sector: A synthesis of evidence and tools*. Washington, DC: The World Bank.  
- **Findings**:  
  - Between 1992 and 2005, the **rise and fall** in U.S. breast cancer incidence rates occurred **only among White non-Hispanic women** who:  
    - Lived in **high-income counties**.  
    - Were aged **50 years and older**.  
    - Had **estrogen receptor (ER)-positive tumors**.  
  - **No Similar Trends**: Among **Black non-Hispanic**, **Asian/Pacific Islander**, **Hispanic**, or **American Indian/Alaska Native women**.  
- **Conclusion**:  
  - The **decline in breast cancer incidence** was **not equally beneficial** to all women.  
  - It **mirrored the social patterning** of **hormone therapy use**, which was more prevalent among affluent White women, reflecting **inequity in access to interventions**.  

---

## ðŸ©º 4. Defining Health Equity  

### ðŸ“– Health Equity  
- **Definition**: *The absence of systematic disparities in health (or its social determinants) between more or less advantaged social groups.*  
  - **Source**: Braveman, P., & Gruskin, S. (2003). *Defining equity in health*.  
- **Social Advantage**: Defined by **wealth**, **power**, and/or **prestige**, which shape social hierarchies.  
- **Impact of Inequities**:  
  - **Disadvantaged groups** face **further health disadvantages**, reducing their **opportunities to be healthy**.  
- **Key Principle**: Health equity ensures **equal opportunity** to be healthy for all.  

### ðŸ¥ Equity in Healthcare: Hypothetical Scenario  
- **Scenario**: A hypothetical country where:  
  - **Children from impoverished households** have:  
    - **Higher prevalence of stunting**.  
    - **Higher incidence of infectious diseases**.  
  - **Equal Clinic Visits**: The annual number of **clinic visits per child** is the same regardless of whether the child is from a poor or rich household.  
- **Analysis**:  
  - **Inequality in Health**: Higher stunting and disease rates among poor children.  
  - **Equality in Healthcare Utilization**: Equal clinic visits across income groups.  
- **Question**: Is this situation **fair or unfair**?  
  - **Opinion**: **Unfair**, as equal clinic visits do not address **underlying social determinants** (e.g., nutrition, sanitation) causing health disparities.  
  - **Role for Government Action**: Interventions to improve **living conditions** (e.g., clean water, food security) are needed to achieve equity.  
- **Key Insight**: *Equal provision of healthcare services does not guarantee equitable health outcomes.*  

---

## âš–ï¸ 5. Resource Allocation and Equity  

### ðŸ“– Allocation of Limited Resources  
- **Hypothetical Scenario in Malaysia**:  
  - An administrator of a rural district receives **RM 50,000** to start a project to improve health. The final list of projects includes:  
    1. **Installation of gravity-feed water system** to provide clean water to 2 remote **Orang Asli** villages (total population: 12 persons).  
    2. **Upgrade dental equipment** to improve preventive dental health services in all schools (benefits 1,200 school children).  
    3. **Family planning services for unmarried young people** to address increased cases of abandoned babies.  
- **Task**: As a member of the **district advisory committee**, choose one project to support and justify the choice.  
- **Evaluation of Projects**:  
  - **1. Gravity-Feed Water System**:  
    - **Arguments in Support**:  
      - **Low baseline health status** of Orang Asli communities indicates **higher needs**.  
      - Clean water addresses **fundamental social determinants**, reducing infectious diseases.  
    - **Arguments Against**:  
      - **Small population (12 persons)** limits overall impact compared to other projects.  
  - **2. School Oral Health Programme**:  
    - **Arguments in Support**:  
      - **Large numbers (1,200 children)** will benefit, maximizing reach.  
    - **Arguments Against**:  
      - **Oral health** in the district is at an **acceptable level**, so the programme may not significantly improve outcomes.  
  - **3. Family Planning Services**:  
    - **Arguments in Support**:  
      - **Reduces abandoned babies**, addressing a pressing social and health issue.  
      - Promotes **reproductive health** and empowerment for young people.  
    - **Arguments Against**:  
      - Potential **cultural resistance**, as services for unmarried youth may be seen as promoting promiscuity.  
- **Considerations**:  
  - **Equity**: Prioritize groups with **greatest need** (e.g., Orang Asli for water, vulnerable youth for family planning).  
  - **Impact**: Balance **number of beneficiaries** with **depth of need** (e.g., clean water for 12 vs. dental care for 1,200).  
  - **Feasibility**: Assess **cultural acceptance** and **implementation challenges** (e.g., family planning stigma).  
- **Not Just a Numbers Game**: Ethical considerations outweigh purely numerical benefits, emphasizing **equity** over **quantity**.  

---

## ðŸ§  6. Ethical Theories in Health Policy  

### ðŸ“– Ethical Dilemma in Health Policies  
- **Summary**:  
  - **Equality in health** is **not possible** due to **biological/genetic causes** that are generally not amenable to interventions.  
  - **Equality in healthcare receipt** may not be the **optimal goal** if it fails to address inequities.  
- **Policy Objectives**:  
  - **Remedy situations** deemed **unfair**, **unjust**, or **inequitable**.  
  - **Determine inequity** through **value judgments**.  
- **Value Judgments in Policies**:  
  - **Resource Allocation**: Who should benefit from limited resources?  
  - **Ethical Basis**: Often **ambiguous** or not **explicitly acknowledged**.  
  - **Implications**: Different ethical positions lead to **different notions of fairness**.  

### ðŸŽ¯ Questions to Ponder  
- **What are the main ethical positions** that guide the allocation of scarce healthcare resources?  
- **Which position is dominant** in your country?  

### ðŸŸ¢ Utilitarianism  
- **Source**: Roberts, M.J., et al. (2004). *Getting Health Reform Right*.  
- **Main Arguments**:  
  1. *What matters are the consequences of health policies on the well-being of individuals.*  
     - The **endpoint (well-being)** is prioritized over the **process** (â€œthe ends justify the meansâ€).  
  2. *The best policy is decided by adding up the gains and losses to all individuals.*  
     - Choose the policy that produces the **greatest good for the greatest number**.  
  3. *Concerned with aggregate welfare, not distribution.*  
     - All individuals are **treated equally**, regardless of disparities.  
- **In Health Policy**:  
  - **Principle**: *Greatest good for the greatest number.*  
  - **Implications**:  
    - May **disregard negative impacts** on minorities if the **total societal benefit** is maximized.  
    - **Equal consideration** can justify **ignoring minority needs** in favor of majority benefits.  
    - Supports policies to **reduce health disparities** only if they **maximize societal welfare**.  
  - **Critique**: May **neglect minority** or vulnerable groups, prioritizing aggregate outcomes over equity.  

### ðŸ”µ Liberalism  
- **Source**: Roberts, M.J., et al. (2004). *Getting Health Reform Right*.  
- **Main Arguments**:  
  1. *Humans have the capacity to develop and implement their own decisions about how to live (life plans) and have a right to do so.*  
  2. *The role of the government is to ensure they are free to exercise these rights and to protect these rights.*  
- **Two Schools**:  
  - **Libertarianism**:  
    - **Focus**: **Negative rights** (freedom from interference, e.g., individual freedom, political, and civil rights).  
    - **Belief**: Advocates for **minimal government intervention**, mainly to protect **property rights** and **personal freedom**.  
  - **Egalitarianism**:  
    - **Focus**: **Positive rights** (entitlements to resources, e.g., right to healthcare).  
    - **Belief**: The **right to choose** is meaningless without **adequate resources**; government should provide a **minimum level of resources** (including healthcare) to ensure **fair equality of opportunities**.  
- **In Health Policy**:  
  - **Egalitarian Liberalism**:  
    - Most frequent position behind policies to **reduce health disparities**.  
    - **Food**, **housing**, and **healthcare** are **preconditions** for meaningful life choices.  
    - A **just society** should equalize these preconditions, using **taxation** for **public financing** of health services.  
  - **Implication**: Supports **publicly funded care** to ensure **equal access** to essential services.  

### ðŸŸ£ Communitarianism  
- **Source**: Roberts, M.J., et al. (2004). *Getting Health Reform Right*.  
- **Main Arguments**:  
  1. *Society is made up of communities of individuals.*  
  2. *Collective values of the community should shape health policies.*  
- **In Health Policy**:  
  - **Community Values**: Policies reflect norms, such as:  
    - **Acceptance/rejection of family planning methods**.  
    - **Acceptance/rejection of practices** like female genital mutilation.  
    - **Role of decision-makers** for healthcare in households.  
  - **Support for Equity**: Policies to reduce health disparities are supported if the community **values equity**.  
  - **Risk**: **Lack of tolerance for minority views** can be justified if they diverge from dominant community norms.  
  - **Critique**: May **suppress minority needs** if community norms prioritize majority values.  

---

## ðŸ‘¥ 7. Individual vs. Population Health  

### ðŸŽ¯ Main Question  
- *Can classical epidemiological methodologies used to examine determinants of diseases in individuals be applied to studies of health inequities?*  

### ðŸ“– Contrasting Approaches  
- **Traditional Clinical (Individual) Approach**:  
  - **Focus**: Individual patient.  
  - **Question**: *Why did THIS patient get this disease?*  
  - **Methods**: Uses **case-control** and **cohort study designs**.  
  - **Requirement**: Needs **heterogeneity of risk factors** among individuals.  
  - **Limitation**: Cannot explain differences in disease incidence in **homogeneous populations**.  
     - **Example**: Would **smoking** be identified as a risk factor for **lung cancer** in a population where **everyone smokes**?  
  - **Source**: Rose, G. (1985). *Sick individuals and sick populations*. *International Journal of Epidemiology*, 14, 32â€“38.  
- **Population Approach**:  
  - **Focus**: Entire populations.  
  - **Questions**:  
    - *Why do some populations have higher rates of a disease while others have lower rates?*  
    - **Example**: Why do some populations have **higher hypertension rates** while others have rare cases?  
  - **Key Insight**: *The determinants of incidence in a population are not necessarily the same as the causes of a disease in an individual.*  
  - **Implication**: Population strategies often **shift the entire distribution** of disease risk, addressing systemic inequities.  

---

## ðŸ›¡ï¸ 8. Prevention Strategies  

### ðŸ“‹ Individual vs. Population Focus  
- **Table: Prevention Strategies**  

| **Focus**      | **Description**                                                                                                                                          |
| -------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Individual** | Screening for high-risk individuals, targeted interventions (e.g., hypertension management).                                                             |
| **Population** | Control determinants of disease incidence through environmental, policy, or societal behavior changes (e.g., mass environmental controls, smoking bans). |

- **Objectives**:  
  - **Individual**: Alter **risk to the individual**.  
  - **Population**: Improve **overall health** of the population by reducing incidence.  
- **Key Insight**: Population strategies have greater potential to address **systemic inequities** by tackling **root causes**.  

---

## ðŸ§± 9. Social Determinants of Health (SDH)  

### ðŸ“– Overview  
- **Definition**: *Health is not simply about individual behavior or exposure to risk, but how the socially and economically structured way of life of a population shapes its health.*  
  - **Source**: WHO Commission on Social Determinants of Health (2008). *Closing the gap in a generation: Health equity through action on the social determinants of health*.  

### ðŸ  Conditions of Daily Life  
- **Key Factors**:  
  - Unfairness in immediate circumstances, such as:  
    - Access to **schools and education** ðŸŽ“.  
    - Access to **healthcare** ðŸ¥.  
    - Access to **conditions of work and leisure** ðŸ§³.  
    - Access to **clean water and sanitation** ðŸ’§.  

### ðŸŒ Structural Determinants  
- **Unequal Distribution of**:  
  - **Power**.  
  - **Money**.  
  - **Goods and Services** (globally, nationally, and locally).  
- **Impact**: These create **systemic barriers** to health equity, perpetuating disparities.  
- **Example**: The **poor health of the poor**, the **social gradient in health** within countries, and **marked inequities** between countries are caused by these structural inequalities.  

---

## âœ… 10. Summary of Key Points  

### ðŸ“‹ Consolidated Takeaways  
- **Table: Key Themes and Takeaways**  

| **Theme**                      | **Takeaway**                                                                                                                                                |
| ------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Inequality vs. Inequity**    | Inequities are **avoidable and unjust** differences, requiring targeted interventions to address systemic barriers.                                         |
| **Ethics in Policy**           | Ethical frameworks (**utilitarianism**, **liberalism**, **communitarianism**) yield varied health priorities, influencing resource allocation and fairness. |
| **Equal Use â‰  Equal Outcomes** | **Structural conditions** (e.g., poverty, access) drive health disparities beyond equal service provision.                                                  |
| **Population Health Focus**    | Systemic interventions are needed to address **population-level** determinants, not just individual cases, to reduce inequities.                            |
| **Social Determinants**        | Addressing **living and working conditions** and **structural inequalities** is critical for health equity.                                                 |

---

# HE 7 - Governmentâ€™s Role in the Health Sector  

**MQB7014: Health Economics**  
**Master of Public Health (MPH) Programme, University of Malaya**  
**Prepared by: Prof. Ng Chiu Wan**  
**Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya**

---

## ðŸ“š 1. Introduction and Objectives  

**Governments** shape health systems to address **market failures**, promote **equity**, and ensure **access to care**, with interventions varying by national ideology (e.g., UKâ€™s NHS vs. USAâ€™s market-based system). This lecture explores the **rationale**, **mechanisms**, and **comparative approaches** for government involvement, focusing on **market dynamics**, **health equity**, and a specific policy discussion on **separating drug prescribing and dispensing** in Malaysiaâ€™s private GP practices.

### ðŸŽ¯ Lecture Contents  
- **Do governments intervene** in the health sector?  
- **What is the basis** for their actions?  
- **What is meant by market failure** in health?  
- **What is equity** in health?  
- **How do governments engage** in the health sector?  

### ðŸ” Recap on Demand for Health and Healthcare  
- **Contribution of Healthcare**:  
  - Healthcareâ€™s role in improving health has **evolved**, with significant impacts **later in life** (e.g., increased life expectancy by 2.0â€“2.5 years at age 65).  
- **Derived Demand**:  
  - **Demand for health** is derived from the need for **utility** (well-being).  
  - **Demand for healthcare** is derived from the demand for health.  
- **Individual as Producer**:  
  - Individuals **actively produce health** through **lifestyle choices** and **medical care investments**.  
- **Demand Dynamics**:  
  - **Suppliers (Providers)**: Influence demand via **payment mechanisms** (e.g., fee-for-service leading to **provider-induced demand**).  
  - **Consumers (Patients)**: Drive demand based on **needs**, **preferences**, and **financial constraints**.  
  - **Third-Party Payers and Moral Hazard**:  
    - **Insurance** reduces **financial risk** but increases **service overuse** due to **moral hazard** (altered behavior when costs are covered).  

---

## ðŸ©º 2. Policy Discussion: Separation of Drug Prescribing and Dispensing in Malaysia  

### ðŸ“‹ Context: Private GP Practice  
- **Task**: *Discuss the merits of a policy on the separation of drug prescribing and dispensing in the context of private GP practice in Malaysia.*  
- **Current Practice**:  
  - In Malaysia, private **General Practitioners (GPs)** typically **prescribe and dispense** medications, integrating both roles in their clinics for convenience and revenue.  
- **Proposed Policy**:  
  - **Separation** mandates that GPs **prescribe** medications, while **pharmacists** handle **dispensing**, aligning with practices in countries like the UK and Australia.  

### ðŸŒŸ Merits of Separation  
- **Reduced Provider-Induced Demand**:  
  - GPs may **over-prescribe** or favor costly drugs to increase revenue, as dispensing is a **profit center**. Separation eliminates this **financial incentive**, ensuring prescriptions align with **clinical need**.  
- **Enhanced Patient Safety**:  
  - **Pharmacists**, as **medication experts**, can **verify prescriptions**, reducing risks of **medication errors**, **drug interactions**, or **inappropriate dosages**.  
- **Increased Transparency**:  
  - Patients receive **clear information** from pharmacists about medications, improving **informed decision-making**, **adherence**, and **health literacy**.  
- **Cost Control**:  
  - Pharmacists may offer **generic drugs** or **competitive pricing**, potentially lowering costs compared to GP-dispensed medications.  
- **Professional Specialization**:  
  - GPs focus on **diagnosis** and **treatment planning**, while pharmacists specialize in **medication management**, enhancing **care quality** and **efficiency**.  

### âš ï¸ Challenges  
- **Access Issues**:  
  - In **rural Malaysia**, pharmacies are scarce, potentially inconveniencing patients who rely on GPs for one-stop services.  
- **Economic Impact on GPs**:  
  - Loss of dispensing revenue could threaten the **financial viability** of private GP practices, particularly small clinics.  
- **Implementation Costs**:  
  - Requires **regulatory frameworks**, **training**, and **pharmacy infrastructure** to support widespread dispensing.  
- **Patient Behavior**:  
  - Patients accustomed to GP convenience may resist visiting pharmacies separately, requiring **public education**.  

### ðŸ“Œ Policy Recommendations  
- **Phased Implementation**: Start with **urban areas** where pharmacy networks are robust, piloting the policy before nationwide rollout.  
- **Support Mechanisms**: Provide **subsidies** or **transition incentives** for GPs and pharmacies to offset revenue losses and infrastructure costs.  
- **Public Awareness**: Launch **campaigns** to educate patients on the benefits of separation (e.g., safety, cost savings).  
- **Rural Considerations**: Develop **mobile pharmacies** or **telepharmacy** solutions to address access gaps in rural areas.  

---

## ðŸ“ˆ 3. Market Dynamics and Government Intervention  

### ðŸ‹ Case Example: Lemonade Market  
- **Market Equilibrium**:  
  - Occurs when **quantity supplied equals quantity demanded** at a given price, achieving **market balance**.  
  - **Graph**: ![[Pasted image 20250518175830.png]]
    ```chartjs
    {
      "type": "line",
      "data": {
        "labels": [0, 20, 40, 60, 80, 100, 120, 140, 160],
        "datasets": [
          {
            "label": "Demand Curve",
            "data": [3.00, 2.50, 2.00, 1.50, 1.00, 0.50, 0.00, 0.00, 0.00],
            "borderColor": "#1f77b4",
            "fill": false
          },
          {
            "label": "Supply Curve",
            "data": [0.00, 0.00, 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 3.00],
            "borderColor": "#ff7f0e",
            "fill": false
          }
        ]
      },
      "options": {
        "title": { "display": true, "text": "Market Equilibrium for Lemonade" },
        "scales": {
          "xAxes": [{ "scaleLabel": { "display": true, "labelString": "Quantity of Lemonade (cups)" } }],
          "yAxes": [{ "scaleLabel": { "display": true, "labelString": "Price per Cup (RM)" } }]
        }
      }
    }
    ```
  - **Equilibrium Point**: At approximately **RM 1.50** and **80 cups**, where supply and demand intersect.  

- **Subsidy to Lemonade Producers**:  
  - A **subsidy** reduces **production costs**, shifting the **supply curve rightward**.  
  - **Impact**:  
    - **Lower price** (e.g., from RM 1.50 to RM 1.00).  
    - **Increased quantity** (e.g., from 80 to 100 cups).  
  - **Graph**: ![[Pasted image 20250518175742.png]]
    ```chartjs
    {
      "type": "line",
      "data": {
        "labels": [0, 20, 40, 60, 80, 100, 120, 140, 160],
        "datasets": [
          {
            "label": "Demand Curve",
            "data": [3.00, 2.50, 2.00, 1.50, 1.00, 0.50, 0.00, 0.00, 0.00],
            "borderColor": "#1f77b4",
            "fill": false
          },
          {
            "label": "Old Supply Curve",
            "data": [0.00, 0.00, 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 3.00],
            "borderColor": "#ff7f0e",
            "fill": false
          },
          {
            "label": "New Supply Curve (with Subsidy)",
            "data": [0.00, 0.00, 0.00, 0.50, 1.00, 1.50, 2.00, 2.50, 3.00],
            "borderColor": "#2ca02c",
            "fill": false
          }
        ]
      },
      "options": {
        "title": { "display": true, "text": "Subsidy to Lemonade Producers" },
        "scales": {
          "xAxes": [{ "scaleLabel": { "display": true, "labelString": "Quantity of Lemonade (cups)" } }],
          "yAxes": [{ "scaleLabel": { "display": true, "labelString": "Price per Cup (RM)" } }]
        }
      }
    }
    ```
  - **Health Relevance**: Subsidies for healthcare (e.g., public clinics, vaccinations) **lower costs** and **increase access**, addressing **market failures**.  

- **Price Floor for Lemonade**:  
  - **Definition**: A **minimum price** set by the government (e.g., RM 1.50 or RM 2.50).  
  - **At RM 1.50**:  
    - **Equilibrium price**: No surplus or shortage, as it aligns with market equilibrium.  
  - **At RM 2.50**:  
    - **Excess supply** (surplus): Suppliers offer **400 cups**, but demand is only **100 cups**, leading to unsold stock.  
  - **Health Example**: Minimum pricing for drugs ensures **provider revenue** but may create **oversupply** or **reduced access** if patients cannot afford higher prices.  

- **Price Ceiling for Lemonade**:  
  - **Definition**: A **maximum price** set by the government (e.g., RM 2.50 or RM 1.50).  
  - **At RM 2.50**:  
    - **Above equilibrium**: No shortage, as suppliers meet demand at **100 cups**.  
  - **At RM 1.50**:  
    - **Below equilibrium**: **Excess demand** (shortage), with demand at **400 cups** but supply at **200 cups**, leading to unmet needs.  
  - **Health Example**: Price ceilings on essential drugs (e.g., generics) ensure **affordability** but risk **shortages** if suppliers reduce production due to low margins.  

### ðŸ“Š Features of Perfect Competition  
- **Characteristics**:  
  - **Many small firms and customers**: No single entity controls the market.  
  - **Identical products**: Consumers are indifferent to providers.  
  - **Freedom of entry and exit**: No barriers to market participation.  
  - **Perfect information**: All parties have full knowledge of prices, quality, and options.  
- **Health Market Deviation**:  
  - Healthcare markets deviate significantly from perfect competition, necessitating **government intervention** to correct inefficiencies.  

---

## ðŸ›ï¸ 4. Rationale for Government Intervention  

### ðŸ“– Why Governments Intervene  
- **Present in Most Countries**:  
  - **Scope and extent** vary by national context (e.g., UKâ€™s centralized NHS vs. USAâ€™s decentralized market-based system; Malaysiaâ€™s dual public-private system vs. Singaporeâ€™s mixed financing).  
- **Productivity Link**:  
  - **Improved health status** enhances **economic productivity**, contributing to national development.  
  - **Causality Debate**: Does health drive productivity, or does economic growth enable better health?  
    - *â€œHealth improvement is a development outcome, not just a consequence.â€* â€” Deaton, A. (2003). *Journal of Economic Literature*, 41, 113â€“158.  
- **Market Failure**:  
  - The **healthcare market** cannot reliably provide **needed care**, **quality**, or **efficiency** due to structural issues.  
- **Equity**:  
  - Governments ensure **fair distribution** of healthcare and health outcomes, addressing disparities across **socioeconomic**, **geographic**, or **vulnerable groups**.  

### ðŸŒ Malaysia Context  
- **GDP per Capita (PPP)**: $9,421.  
- **Life Expectancy at Birth**: 72 years.  
- **Implication**: Malaysiaâ€™s dual healthcare system (public and private) reflects government efforts to balance **equity** (public subsidies) and **market efficiency** (private sector growth).  

### âš–ï¸ Equality vs. Equity  
- **Equality**:  
  - *Equal treatment for every person, regardless of need.*  
  - May not be ideal in health, as needs vary (e.g., sicker patients require more care).  
- **Equity**:  
  - *Involves moral and ethical dimensions, representing equality with fairness and distributive justice.*  
    - **Source**: Mulholland, E. K., et al. (2008).  
  - *Refers to differences in health that are unnecessary, avoidable, unjust, and unfair.*  
    - **Source**: Whitehead, M. (1990).  
  - *The absence of systematic disparities in health (or its social determinants) between social groups with different levels of social advantage/disadvantage.*  
    - **Source**: Braveman, P., Gruskin, S. (2006).  
- **Government Role**: Promote **equity** by ensuring **access to care** as a **fundamental right**, particularly for the **poor** and **vulnerable**, countering **free market inefficiencies**.  

---

## ðŸ“‰ 5. Market Failures in Health  

### ðŸ“‹ What is Market Failure?  
- **Definition**: *Situations where the market fails to allocate resources efficiently, leading to suboptimal healthcare outcomes.*  
- **Health-Specific Failures**:  
  - **Public and Merit Goods**: Under-provided by markets.  
  - **Externalities**: Benefits or costs affecting third parties.  
  - **Insurance Market**: Issues like **adverse selection** and **moral hazard**.  

### ðŸ” Deviations from Perfect Competition  
- **Provider Consolidation**:  
  - **Evolution**: From **single/small entities** to **large, organized structures** (e.g., hospital chains, pharmaceutical conglomerates).  
  - **Reason**: **Economies of scale** reduce **unit costs** (average costs decrease as production scales).  
  - **Impact**: Creates **monopolies** or **oligopolies**, reducing competition and increasing costs.  
  - **Malaysia Example**:  
    - **Single Practitioner Clinics**: Traditional small-scale GP practices.  
    - **Group Practices (Panel Doctors)**: Collaborative models under insurance or corporate schemes.  
    - **Managed Care Organizations (MCOs)**: Large-scale providers integrating services for efficiency.  
- **Product Differentiation**:  
  - Healthcare is **not homogeneous**; private providers compete on **perceived quality** rather than just price.  
  - **Examples**:  
    - Adoption of **high-tech medicine** (e.g., advanced diagnostics).  
    - New **treatment modalities** (e.g., minimally invasive surgeries).  
    - Recruitment of **senior, well-known doctors** to attract patients.  
- **Entry Restrictions**:  
  - **Training Limits**: Restricted admissions to **medical schools** and **recognition** of institutions.  
  - **Licensure**: Providers must meet **regulatory requirements** (e.g., pre-Brexit restrictions on non-EU doctors in the UK).  
  - **Malaysia Example**: Limited medical school seats and strict licensing by the Malaysian Medical Council.  
- **Ethical Constraints**:  
  - **Code of Practice**: Prohibits **advertising** or **competing with colleagues** in some countries, limiting market dynamics.  
  - **Malaysia Example**: Malaysian Medical Association guidelines restrict overt advertising by doctors.  
- **Intellectual Property Rights and Patents**:  
  - **Patents**: Grant **exclusive rights** for pharmaceuticals and medical devices for a limited time, preventing others from producing or selling the product.  
  - **Impact**: Reduces **competition**, restricts production to patent holders, and increases **costs**.  
  - **Example**: High-cost patented drugs limit access in Malaysiaâ€™s private sector.  
- **Asymmetry of Information**:  
  - Patients lack **perfect information** due to the **technical nature** of medical knowledge, requiring training to understand.  
  - **Provider Behavior**:  
    - Doctors may **withhold information** to avoid distressing patients (e.g., fearing patients cannot handle â€œbadâ€ diagnoses).  
    - Even when **full information** is provided, patients may not comprehend enough to make **informed decisions**.  
  - **Malaysia Example**: Patients often rely on GP expertise, exacerbating information gaps.  
- **Provider-Induced Demand**:  
  - Providers may **over-provide services** (e.g., unnecessary tests, procedures) to increase income, especially under **fee-for-service** models.  
  - Driven by **financial incentives** or **investments** in healthcare facilities (e.g., diagnostic equipment).  
  - **Malaysia Example**: GPs dispensing medications may prescribe more to boost revenue, a key issue in the separation policy debate.  

### ðŸ›¡ï¸ Public and Merit Goods  
- **Public Goods**:  
  - *Economic goods that are non-rivalrous (consumption by one does not reduce availability) and non-excludable (cannot prevent access once provided).*  
  - **Examples**:  
    - **Health information** (e.g., public health campaigns on dengue prevention).  
    - **Clean air** and **non-polluted rivers** (environmental health).  
    - **Lighthouses** (analogous to universal benefits).  
- **Public Goods in Health**:  
  - **Information on health** (e.g., Malaysiaâ€™s MySejahtera app for COVID-19 updates).  
  - **Environmental measures** (e.g., clean water initiatives).  
- **Merit Goods**:  
  - *Goods under-consumed in markets because users prioritize personal utility, ignoring positive externalities or long-term benefits.*  
  - **Examples**:  
    - **Vaccines** (e.g., Malaysiaâ€™s National Immunization Programme).  
    - **Vector control** (e.g., fogging for dengue).  
    - **Screening programs** (e.g., breast cancer screenings).  

### ðŸŒ Externalities in Health  
- **Definition**: *Costs or benefits from a decision that affect individuals or groups other than the decision-maker.*  
- **Types**:  
  - **Negative Externality**:  
    - Causes **harm** to others (e.g., **secondhand smoke**, **pollution**).  
    - **Example**: Smoking in public spaces in Malaysia, addressed by **smoking bans**.  
  - **Positive Externality**:  
    - **Benefits** others (e.g., **immunization** conferring **herd immunity**).  
    - **Example**: Malaysiaâ€™s high vaccination rates for childhood diseases protect communities.  
- **Health Example**:  
  - **Preventive measures** like **mass immunization** protect unvaccinated individuals, justifying government funding.  

### ðŸ›¡ï¸ Insurance Market Failures  
- **Causes**:  
  - **Information Asymmetry**:  
    - **Adverse Selection**: High-risk individuals are more likely to buy insurance, increasing **premiums**.  
    - **Impact**: Excludes the **poor** and drives **healthy individuals** out of the market.  
    - **Example**: Malaysiaâ€™s private insurance market sees limited uptake among low-income groups.  
  - **Moral Hazard**:  
    - Insured individuals **overuse services** (e.g., unnecessary consultations) due to reduced **perceived costs**.  
    - **Example**: Overuse of private clinic visits under corporate insurance plans in Malaysia.  
- **Consequences**:  
  - **Unaffordable insurance** for low-income groups.  
  - **Cost escalation** due to increased utilization.  
  - **Market Failure**: Insurance markets may not develop adequately without intervention.  
- **Government Response**:  
  - Develop **Social Health Insurance (SHI)** to ensure **broad coverage** and mitigate market failures.  
  - **Malaysia Example**: Proposals for a national SHI to complement the public system.  

### ðŸ”§ Correction of Market Failures  
- **Market Shortcomings**:  
  - Individuals **under-utilize** public/merit goods with **positive externalities** or **long-term benefits** (e.g., skipping screenings).  
  - Many remain **uninsured** due to high premiums.  
  - **Negative externalities** (e.g., smoking) persist without intervention.  
- **Government Tools**:  
  - **Subsidies**: Fund public/merit goods (e.g., Malaysiaâ€™s free vaccinations).  
  - **Direct Provision**: Operate public hospitals and clinics.  
  - **Financing**: Support insurance for the poor (e.g., Malaysiaâ€™s public healthcare subsidies).  
  - **Pigouvian Taxes**: Target **negative externalities** (e.g., **carbon taxes**).  
  - **Sin Taxes**: Discourage harmful consumption (e.g., Malaysiaâ€™s **tobacco** and **alcohol** taxes).  

---

## ðŸ›ï¸ 6. Mechanisms of Government Intervention  

### ðŸ“‹ How Governments Intervene  
| **Method**      | **Description**                                | **Examples**                                                                                                                                 |
| --------------- | ---------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------- |
| **Information** | Provide data to enable **informed decisions**. | Health promotion campaigns (e.g., Malaysiaâ€™s anti-dengue campaigns), clinical guidelines.                                                    |
| **Regulation**  | Use **legal powers** to impose constraints.    | Compulsory immunization, provider licensing, hospital distribution, quarantine for infectious diseases (e.g., Malaysiaâ€™s COVID-19 measures). |
| **Mandates**    | Grant **authority** for specific actions.      | Ministry of Health collecting surveillance data (e.g., Malaysiaâ€™s disease reporting system).                                                 |
| **Delivery**    | Provide **public healthcare services**.        | Public hospitals, clinics (e.g., Malaysiaâ€™s Klinik Kesihatan).                                                                               |
| **Financing**   | Fund services to **subsidize care**.           | Subsidies for the poor, funding public/merit goods (e.g., Malaysiaâ€™s subsidized public healthcare).                                          |

### ðŸ“¢ Information Provision  
- **Health Promotion Campaigns**: Educate the public on **health choices** (e.g., Malaysiaâ€™s **Tak Nak** anti-smoking campaign).  
- **Provider Information**: Disseminate **clinical guidelines** and **therapy effectiveness** data to improve care quality.  
- **Impact**: Reduces **information asymmetry**, enhances **accessibility**, and empowers **patients** and **providers**.  

### ðŸ“œ Regulation  
- **Purpose**: Address **imbalances** and **protect public health**.  
- **Examples**:  
  - **Compulsory immunization** (e.g., Malaysiaâ€™s childhood vaccination mandates).  
  - **Licensing** of doctors and pharmacists.  
  - **Hospital distribution** for equitable access (e.g., Malaysiaâ€™s public hospital network).  
  - **Quarantine** for infectious diseases (e.g., Malaysiaâ€™s Movement Control Order during COVID-19).  

### ðŸ”’ Mandates  
- **Definition**: *Authority granted to perform specific actions.*  
- **Example**: Malaysiaâ€™s Ministry of Health mandated to collect **surveillance data** for disease monitoring (e.g., MySejahtera for COVID-19 tracking).  

### ðŸš‘ Service Delivery  
- **Public Provision**: Governments operate **hospitals**, **clinics**, and **primary care** to ensure access, especially for **vulnerable groups**.  
- **Malaysia Example**: Nationwide **Klinik Kesihatan** and public hospitals provide subsidized care.  

### ðŸ’° Financing  
- **Objectives**:  
  - **Subsidize basic care** for the poor (e.g., Malaysiaâ€™s low-cost public healthcare).  
  - **Target vulnerable groups** (e.g., elderly, low-income).  
  - **Correct externalities** by funding public/merit goods (e.g., free vaccinations).  

### ðŸŒ Health System Goals (WHO, 2000)  
- **Improve population health**.  
- **Meet peopleâ€™s expectations**.  
- **Provide financial protection** against ill-health costs.  
- **Equity Focus**:  
  - Systems designed for **universal coverage** prioritize **socially disadvantaged** and **marginalized groups**, ensuring **fair access**.  
  - **Source**: The World Health Report 2000; Knowledge Network on Health Systems, WHO Commission on the Social Determinants of Health, 2000.  

---

## ðŸŒŽ 7. Comparative Health Systems: USA vs. UK  

### ðŸ‡ºðŸ‡¸ Health Care in the USA  
- **Context**:  
  - An **affluent, industrialized country** with **high health expenditures** (16.9% of GDP in 2018).  
  - A **federated nation** with **decentralized governance** to states, counties, and communities.  
  - Strong belief in a **free market economy** and **laissez-faire** health system management.  
  - The **only wealthy, industrialized nation** without **universal insurance coverage** (8.9% uninsured in 2016).  
- **Delivery System**:  
  - **Predominantly private**: Includes hospitals, clinics, pharmacies, etc.  
  - **Public Facilities**: **Veterans Affairs (VA) hospitals** serve veterans only.  
  - Significant presence of **non-profit facilities**.  
- **Financing System**:  
  - Providers paid via **insurance funds** (employer-based or individual) and **out-of-pocket (OOP) payments**.  
  - **Insurance Coverage**:  
    - Mainly through **employer-sponsored group insurance**.  
    - Less common **individually purchased insurance**.  
    - **Safety Nets**:  
      - **Medicare**: For the elderly.  
      - **Medicaid**: For low-income individuals.  
      - **Veterans Health Administration**: For veterans.  
- **Challenges**:  
  - **Cost Escalation**: Driven by:  
    - **Over-reliance on insurance**.  
    - **Moral hazard** (overuse of services).  
    - **Provider-induced demand** (e.g., unnecessary tests).  
    - Led to **managed care** (e.g., **Health Maintenance Organizations**), raising **ethical** and **business concerns**.  
  - **Insurance Gaps**: Large groups (e.g., **unemployed**, **poor**) lack adequate coverage.  
  - **Universal Coverage Efforts**: Multiple unsuccessful attempts to implement (e.g., pre-Affordable Care Act debates).  

### ðŸ‡¬ðŸ‡§ Health Care in the UK  
- **Context**:  
  - Rooted in the **Welfare State**, established post-World War II via the **Beveridge Report (1942)**.  
  - Identified five â€œGiant Evilsâ€: **squalor**, **ignorance**, **want**, **idleness**, and **disease**.  
  - Government commitment to care â€œ**from cradle to grave**â€ through **health**, **education**, **employment**, and **social security**.  
- **National Health Service (NHS)**:  
  - Established in **1948**, comprising four **single-payer, publicly funded** systems:  
    - **NHS England**, **NHS Scotland**, **NHS Wales**, **Health and Social Care in Northern Ireland**.  
- **Financing**:  
  - Funded by **general taxation** and **national insurance**.  
  - Most services are **free at the point of service** for UK residents, based on **need**, not **ability to pay**.  
  - **Fees** charged for **prescriptions**, **dental**, **optical**, and other **non-funded services**.  
- **Delivery of Care**:  
  - **Commissioning agencies** purchase care from diverse providers.  
  - Uses **competition** and **strategic purchasing** to enhance **efficiencies**.  
  - Guided by the **National Institute for Health and Care Excellence (NICE)** for **cost-effectiveness**, issuing guidelines on **health technology**, **clinical practice**, **health promotion**, and **safe practices**.  
- **Challenges**:  
  - **Long waiting times** for non-emergency services.  
  - **Therapy selection** for funding, balancing cost and benefit.  
  - Continuous **service quality** improvement.  

### ðŸ“Š Key Indicators: UK vs. USA (2018â€“2020)  
| **Indicator**                                                | **UK**     | **USA**     |
| ------------------------------------------------------------ | ---------- | ----------- |
| **Total Population (2020, millions)**                        | 67.2       | 329.5       |
| **Population under 15 years (%)**                            | 17.7%      | 18.4%       |
| **Population over 65 years (%)**                             | 18.7%      | 16.6%       |
| **Doctors per 1,000 population**                             | 2.8 (2018) | 2.6 (2017)  |
| **Nurses per 1,000 population**                              | 8.2 (2018) | 14.5 (2017) |
| **Hospital Beds per 1,000 population (2013)**                | 2.5 (2019) | 2.9 (2017)  |
| **Current Health Expenditure (% of GDP, 2018)**              | 10.0       | 16.9        |
| **Current Health Expenditure per Capita (PPP, 2018)**        | $4,620     | $10,624     |
| **Domestic General Government Expenditure (% of CHE, 2018)** | 78.6       | 50.4        |
| **Infant Mortality Rate (per 1,000 live births)**            | 3.7 (2018) | 5.6 (2019)  |
| **Life Expectancy at Birth (2019, years)**                   |            |             |
| - Males                                                      | 79.4       | 76.3        |
| - Females                                                    | 83.1       | 81.4        |
| - Total                                                      | 81.2       | 78.8        |
- **Source**: World Development Indicators, accessed 1.12.21.  
- **Note**: Nurse data reconciled from slides (8.2 for UK vs. 5.2 in earlier summary), prioritizing slide accuracy.  

---

## âœ… 8. Summary of Key Concepts  

| **Theme**               | **Takeaway**                                                                                                                                |
| ----------------------- | ------------------------------------------------------------------------------------------------------------------------------------------- |
| **Why Intervene?**      | Address **market failures**, promote **equity**, and link **health to productivity** (Deaton, 2003).                                        |
| **Equality vs. Equity** | **Equity** prioritizes **fairness** over equal treatment, addressing **avoidable disparities** (Whitehead, 1990; Braveman & Gruskin, 2006). |
| **Market Failures**     | Driven by **public/merit goods**, **externalities**, **information asymmetry**, and **insurance issues** (adverse selection, moral hazard). |
| **Corrective Tools**    | **Subsidies**, **taxes** (Pigouvian, sin), **regulation**, **mandates**, and **direct provision** to correct market failures.               |
| **System Design**       | **Ideology** shapes systems (UKâ€™s **NHS** vs. USAâ€™s **market-based**; Malaysiaâ€™s **dual system** vs. Singaporeâ€™s **mixed financing**).      |
| **Health System Goals** | **Improve health**, **meet expectations**, and **provide financial protection**, with a focus on **equity** (WHO, 2000).                    |

---
